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PREFACE
This report covers the activities of the Research Triangle Insti-
tute's Biomedical Applications Team program for the period 1 January,
1977 through 31 December 1977. The work was performed in the Center
for Technology Applications under the technical direction of Dr. J. N.
Brown, Jr., Director. Or. R. W. Scearce was the Biomedical Applications
Team Director. Assistance with the development of marketing strategy
was provided by Dr. W. H. Clingman of W. H. Clingman and Company, Inc.,
a marketing and management consulting firm. Other participants in the
program were Dr. H. C. Beall, Ms. D. J. Rouse, and Mr. J. C. Ruddle.
The work reported herein was supported by the National Aeronautics
and Space Administration--Contract No. NAS1 - 14108. Mr. John Samos, Head,
Technology Utilization and Applications Programs Office, Langley Research
Center, was the Technical Monitor. Ms, Sheila Ann T. Long, Technology
Utilization Engineer--Biomedical Programs, was the alternate Technical
Monitor.
The authors gratefully acknowledge the contributions of many indi-
viduals to the success of the RTI Biomedical Applications Team program.
The time and effort contributed by managers, engineers, and scientists
throughout the National Aeronautics and Space Administration and that of
medical researchers and clinicians were absolutely essential to program
success. Industry managers and technical staff have always been co-
operative and open in their participation. Dr. W. H. Clingman has
increased the team's understanding of medical manufacturing and marketing
practices and how these practices impact medical technology transfer. Dr.
William A. Fischer. Assistant Professor. School of Blusiness Administration,
University of North Carol ina at Chapel Hill. has contributed much to the
teai'Os understanding of and approacn to techrnoloTv transfer. The continued
interest in, support of, and contribution to the team's efforts by Dr.
F. Thomas Wooten, Executive Assistant to the [`resident, RTI, are consid-
erable and are appreciated, Finally, Mr. John Samos and Ms. Sheila Long
have contributed significantly to the success of the program, and, as
technical monitors, they have always been supportive and understanding.
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ABSTRACT
The objective of the Research Triangle Institute (RTI) Biomedical
Applications Team is to achieve widespread utilization of National
Aeronautics and Space Administration (NASA) technology in medicine.
This objective is best approached by stimulating the introduction of
new, commercially available, medical products incorporating aerospace
technology.
A bipolar, donor-recipient model of medical technology transfer is
introduced to provide a basis for the team's methodology. That
methodology is designed (1) to identify medical problems and NASA tech-
nology that in combination constitute opportunities for successful
medical products, (2) to obtain the early participation of industry in
the transfer process, and (3) to obtain acceptance by the medical
community of new medical products based on NASA technology.
Two commercial technology transfers and five institutional tech-
nology transfers were completed in 1977. A new, commercially available
teaching manikin system uses NASA-developed concepts and techniques for
effective visual presentation of information and data. Drugs shipped
by the National Cancer Institute to locations throughout the world are
maintained at low temperatures in shipping containers that incorporate
recommendations made by NASA. A clinical information system that enhances
medical and surgical treatment of ischemic heart disease patients at
Duke University Medical Center incorporates NASA image processing tech-
nology.
The team's emphasis on commercial technolog y transfers is reflected
in the character of transfer cases active in Decermber 1977: twenty-six
of twenty-eight active cases have potential for becoming commercial
transfers.
For the convenience of the reader, the names and addresses of the
sources of certain commercial products are included in this report. This
listing does not constitute an endorsement by either the National Aero-
nautics and Space Administration or the Research Triangle Institute.
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1.0 INTRODUCTION	 0^ POW QUALITY
The preamble to the Space Act of 1958 creating the National Aeronau-
tics and Space Administration (NASA) expressed clearly: "It is the
policy of the United States that activities in space should be devoted to
peaceful purposes for the benefit of all mankind." 1 Further, this Act
of Congress charged NASA to "provide for the widest practical and
appropriate dissemination of information concerning its activity and the
results thereof." The NASA Technology Utilization Program was initiated
in 1962 to assist in satisfying this Congressional obligation.
Since 1962, NASA has been a leader and an innovator in the establish-
ment, operation, and evaluation of technology transfer programs. Through
its Tech Brief, Special Publications, Technology Survey, and Industrial
Applications Center programs, NASA has successfully transferred the
results of aerospace research to the non-space related sectors of society.2
In 1966, NASA introduced a new approach to technology transfer that
involved the activities of multidisciplinary "applications teams." The
objective of these applications teams -- called Biomedical Applications
Teams -- was to effect the transfer of NASA technology to applications in
medical research and cliniLal medicine. The general approach of the
Biomedical Applications Teams was: (1) to identify medical problems
through direct interactions with clinicians and medical researchers;
(2) to identify potentially applicable NASA technology by a variety of
mechanisms; and, (3) to take whatever action was necessary and appropriate
to effect actual utilization of NASA technology involving technology-
related medical problems.
Since the establishment of the applications team program in 1966,
NASA has applied the applications team concept in the transfer of tech-
nology to applications in: (1) environmental science; (2) housing
construction; (3) transportation; and, (4) manufacturing processes.
At present Biomedical Applications Teams are sponsored by NASA at
the following institutions:
Research Triangle Institute
Post Office Box 12194
Research Triangle Park, North Carolina 27709
Stanford University School of Medicine
701 Welch Road	 ORIGINAL PAGE Is
Palo Alto, California 	 94304 OF POOR QUALITY
University of Wisconsin
1500 Johnson Drive
Madison, Wisconsin	 54706
This report presents the activities and accomplishments of the Biomedical
Applications Team located at the Research Triangle Institute for the
period 1 January 1977 through 31 December 1977.
1.1 Biomedical Applications Team Objectives
The primary objective of the Research Triangle Institute (RTI)
Biomedical Applications Team is to assist NASA in acnieving widespread
utilization of aerospace technology in the medical field. Widespread
utilization implies that, by the application of NASA technology in medicine,
a significant sector of the medical field and of those seeking medical
services realize some benefit. Implicit in this program objective is that
widespread utilization be realized in a relatively rapid manner.
The successful transfer of NASA technology to applications in the
medical field via the Biomedical Applications Team program has been
demonstrated. 2-5 NASA technology has been successfully applied to ap-
plications in both clinical medicine and in medical research. These
applications have resulted in advances in medical research, improved
clinical diagnosis and treatment, and the introduction of beneficial new
or improved medical products.
While advances in medical research ultimately hive widespread positive
i;npact on the delivery of healch care in the U.S., wedicil research
is a slow, complex, and expensi%.e process. On the other hand, there is
potentially much that can be accomplished in a relativel y short time by
solving technology-related problems in clinical medicine. Applications
of technology in clinical medicine usually involve the introduction of a
new or improved, commercially available, medical product.
Thus, the approach of the NASA Biomedical Applications Teams in
obtaining widespread utilization of NASA technology is to direct its efforts
c
primarily to solving problems that involve the introduction of a new or
improved medical product. It should be noted that the team do not
ignore opportunities for applying NASA technology in medical research.
This emphasis on achieving widespread utilization by commercializing
NASA technology is reflected in the activities and methodology of the
Biomedical Applications Team program. The team methodology is built
around the following four activities: (1) the identification of medical
problems and needs and potentially applicable NASA technologies that
together constitute a new or improved medical product; (2) screening of
opportunities to identify those that represent potentially successful
commercial products; (3) the development of cotmtercielization strategies
that take into account any necessary adaptation of NASA technology,
evaluations and clinical trials, FDA regulations, manufacturer's
marketing systems, and required funding; and, (4) implementation and
monitoring of commercialization strategies. These tasks are discussed in
more detail in section 2.0, Technical Approach.
1.2 Biomedical Applications Team
The RTI Biomedical Applications Team is a multidisciplinary
team of engineers and scientists. Their educational backgrounds are
physiology, biophysics, engineering, biochenistrv, and biomedical
engineering; their experience includes basic and applied research,
development, and marketing. The individuals who participated in the
Biomedical Applications Team program during the reporting period are:
Name
Dr. J. N. Brown, Jr.
Dr. R. W. Sceerce, Jr.
D ►• . W. H. Cli,igman*
Dr. H. C. Beall
Mr. J. C. Ruddle
Ms. D. J. Rouse
Educational
Background
Electrical Engineer
Biomedical Engineer
Chemical Engineer
Biophysics, Physiology
Biomedical Engineer
Biochemist, Physiology
Resoor.s i bi 1 i t
Laboratory Supervisor
Team Director
Marketing Consultant
Solution Specialist
Solution Specialist
Solution Specialist
oraGWAL rACE TB
OF PWR QUALITY
*
Dr. Clingmar, William 11, rlingman and Company, Inc.. ► ti a marketing and
management cory u l t .int to ttr•.earch Triangle I n%ti t ut e.
I
The Biomedical Applications Team may be viewed as one component
in a technology transfer network that involves individuals at NASA
Headquarters, NASA Field Centers, medical institutions, manufacturing
and marketing firms, and other individuals, groups, and organizations
concerned with medical technology transfer.
1.3 Participating Institutions
At present, medical researchers and clinicians from 27
medical institutions participate in the RTI Biomedical Application Team
program. Medical researchers and clinicians participate in the program
in the following ways: (1) identify medical problems and needs appropriate
for investigation by the Biomedical Applications Team; (2) serve as a
knowledge base on medical problems and needs, markets, and potential
applications of NASA technology; and, (3) are recipients of NASA tech-
nology to be applied in their medical research programs or to be evaluated
within their clinical practice. Participating institutions are listed
in table 1. Figure 1 presents the geographical locations of participating
medical institutions and NASA Field Centers.
1.4 Conference Attendance
biomedical Applications Team vembers attend and participate in
conferences and workshops to remain thouroughly familiar with the state-
of-the-art of medical technology and to discuss new product opportunities
with medical industry representatives. Conference attendance and presenta-
tions are listed in appendix C.
1.5 Report SunrnarY
The Biomedical Applications Team's technical approach to
technology transfer in medicine is described in section .0. Emphasis
on coiwiiercialization of NASA technology is evident in the overall structure
of the team's methodology. That is, the team's activities are segmented
into four major phases leading logically from the identification of op-
portuilities for t..UIIIII0'LidliZatiUII to the implevit-ntdtion and monitoring of
coiniercialization strategy. Within each of the four major phases of team
activit y , program flexibility allows for technology transfer activities
related to medical research and leadino to institutional technology transfer.
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FBowman Gray School of Medicine, Wake Fore s t University,
Winston-Salem, North Carolina (WF)*
Carnegie-Mellon Institute of Research, Pittsbugh,
Pennsylvania (CM)
Dorothea Dix Hospital, Raleigh, North Carolina (DIX)
Duke University Medical Center, Durham, North Carolina (includ-
ing Veterans Administration Hospital, Durham, North Carolina) (DU)
Emory University School of Medicine, Atlanta, Geornia (EU)
Eye Research Institute of Retina Foundation, Boston,
Massachusetts (ERI)
Guilford Co!+nty Communications Center for the Deaf, Greensaoro,
North Carolina (GCCC)
Hahnemann Medical College, Philadelphia, Pennsylvania (HMC)
Institute for Cancer R.-search, Philadelphia, Pennsylvania (ICR)
Jefferson Medical College, Philadelphia, Pennsylvania (JEF)
Johns Hopkins University Medical School, Baltimore, Maryland (JHU)
Louisiana State University School of Dentistry, Baton Rouge,
Louisiana (LSD)
Medical College of Virginia, Richmond, Virginia (MCV)
Medical University of South Carolina; Charleston, South
Carolina (MUSC)
Mount Sinai Medical Center, New York, New York (MS)
National Cancer Institute, Bethesda, Maryland (NCI)
Letters in parentheses are used in identifying problems investigated by
the Biomedical Applications Team; e.q.. 'dF-1 is identification code for
prublem number I originated at tiuwuarn (WAY SL110U1 of Medicine. Wake
Forest University.
0^^ PAGE IS
TABLE 1. (Mme)
KMonal Heart, lung, and Blood Institute, bethesda,
Maryland ((I)
Temple Universit School of Medicine, Philadelphia,
Pennsylvania (TE
Tulane University School of Medicine, New Orleans,
Louisiana (TU)
United Cerebral Palsy Association of Nassau County, New
York (UCP)
University of Georgia College of Veterinary Medicine, Athens
Georgia (UGA)
University of Miami School of Medicine, Miami, Florida, (in-
cluding Veterans Administration Hospital, Miami, Florida) (VAM)
University of Mississi ppi Medical Center, Jackson,
Mississippi (UMISS)
University of North Carolina School of Medicine, Chapel Hill,
North Carolina ;UNC)
University of North Carolina Dental School and Research Center,
Chapel Hill, North Carolina IJNCD,l
Veterans Administration resaital, :?teen, North Carolina (VAO)
Woodrow Wilson Rehabilitation Center, Fishersville, Virginia (WWRC)
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Technology transfers brought to fruition during the reporting period
are documented in section 3.0. Two commercial technology transfers and
five institutional technology transfers are documented. This documentation
describes the technology transfer, the situational context to which the
technology was transferred, and the role of the Biomedical Applications
Tema as 11 transfer ac`jent.
The technology transfer activities of the Biomedical Applications
	 \ d
Team are summarized in section 4.0. Medical problems and needs identified
during the reporting period are documented. The status of the team's
investigation of these problems is documented. The status of 13 potential
technology transfers is described and progress in strategy development
and implementation is documented.
. Section 5.0 is a statement of conclu°ions and recommendations.
Emphasis in this statement is on what has been learned concerning medical
technlogy transfer and how these lessons may be applied in increasing the
productivity of the NASA Biomedical Applications Team program in general.
1.6 Definition of Terms
Biomedical Applications Team (team -- A multidisciplinary
team of engineers and scientists engaged in assisting NASA in achieving
widespread utili ,ation of aerospace technology in the medical field.
Corms rcial upportunity -- The combination of a significant
medical need or problem and appropriate, relevant NASA technology that
together constitute the basis for a potentially successful, new or improved,
conmercial medical product.
Conrrtercial technology transfer -- The successful deu_•ioponent
.and marketing of a new or improved medical product that incorporates NASA
technology.
Computer information search -- A computerised search of NASA'F
aerospace information bank at one of six Industrial Applications Centers
(IAC). This information bank consists of more than one million documents
that have been indexed and abstracted in the Scientific and Technical
Aerospace Reports (STAR) and the International Aerospace Abstracts (IAA).
DE POOR QUAU
-
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r -- Organization or individual that originally developed
technology that is transforrod. Within the context of the giondital
Applications Team, thedoeor is the National lieronautics and Space Administra-
tion.
Institutional technology transfer -- The application of MSA
technology to solve a significant radical problem that does not result
in a now or unproved medical product.
Medical problem or need -- A specific and definable, tech-
nology-related, medical problem or need that cannot be satisfied by
coimercially available equipment or by the application of information
that is availdb le to the problem originator through routinely used
information channels.
Participating institution -- A medically-oriented educational
institution, hospital, medical center, or government agency that
participates with the Biomedical Applications Team in identifying medical
problems and needs and in evaluating NASA technology that represents
solutions to these problems and needs.
Potential transfer -- The identification of technology that
potentially solves a particular medical problem or meets a need and the
identification of strategy for achieving commercialization or implementa-
tion.
Problem _originator= -- A clinician or medical researcher actively
involved in reaching % specific medical objective and faced with a
specific technology-related problem or need.
Problem statement -- A concise, written statement of a medical
problem or need that containa. (;) sufficient details to allow a computer
search to be performed, rind, t2j ,ufficient information to enable NASA
engineers and scientists to cinsider possible solutions.
Rec_i1i nt
	 The clinical avdic:al sector or medictrl researched`
that uses or applies technology tramferred.
RTOP (Research and Technology ObJektives and Plans)-- A
proposal submitted by a NASA field Center to NASA Headquarters for funding
Of R & ti pro,leet ire general Mid, in nrarticular, for funding to oklapt NASA
teihnolotty for appirc.,ltion in owdic.irit1,
ORIGINAL PAGE I
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Transfer agent (or linker} -- The individual or organization,
the Biomedical Applications Team, that plans, stimulates, and facilitates
Let- 1111olog trall-Jer,
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Transfer agent (or linker) -- The individual or organization
the Biomedical Applications Team, that plans, stimulates, and facilitates
OMOM PAGE IS
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2.0 TECHNICAL APPROACH 	 OF POOR QUALi T Y
The conceptual framework for medical technology transfer presented
in section 2.1 facilitates the description of and supplies a rationale
for the Biomedical Applications Team methodology.
2.1 Conceptual Framework for Medical Technology Transfer
A conceptual framework for medical technology transfer is
presented diagrammatically in figure 2. 6 The framework is basically a
bipolar, donor-recipient model. The role of the donor, in this case NASA,
is to reveal, disseminate, and promote technology. The role of the
recipient, the medical community, is to seek out, evaluate, and utilize
technology.
As explained in the Introduction, the primary thrust of the Bio-
medical Applications Team program is to transfer technology by the intro-
duction of new and improved medical products. Thus, a manufacturer of
those products is included in figure 2. Medical technology transfer
normally involves the identification of a medical problem or need within
the medical community. In response, the National Aeronautics and Space
Administration recognizes the relevance of specific aerospace technology
and makes that technology available. The manufacturer designs, develops,
evaluates, and markets a new or improved medical product that incorporates
the aerospace technology and that represents a solution to the medical
problem or need.
The purpose of the transfer agent in this framework is to plan,
stimulate, and facilitate such technology transfer. This is the role of
the Biomedical Applications Team.
Research into the process of medical technology transfer at the
Syracuse University Research Center has concluded teat the donor, recipient,
and manufacturer are frequently at cross purposes. 7 The recipient is
primarily and appropriately concerned only with solving a problem. The
manufacturer by necessity is concerned with introducing a commercially
The terminology ''linker" is fregL",ntly used in this context.
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viable product. And. the donor obtains only satisfaction as reward for
involvement in the transfer process. It is the task of the transfer
agent to bring the donor, recipient, and manufacturer together in such
a way that each views successful technology transfer as the primary
objective. Completeness of the transfer effort must be a major goal for
all parties involved.
The specific role of the Biomedical Applications Team, the transfer
agent, depends significantly upon the motivation, competence, and organiza-
tion of the donor, recipient. and manufacturer. NASA is highly motivated
to transfer aerospace technology to applications in non-space related
fields. Further, its organization is structured to facilitate the develop-
ment of sophisticated and advanced technology. NASA's understanding of
the medical industry and clinical medicine, on the other hand, are not
great. The technological competence of the recipient is highly variable.
Many medical researchers in large medical centers and teaching hospitals
are technologically competent; the physician in clinical practice, in
general. will not be technologically competent. The manufacturer of
medical products may have a long and successful history of developing and
marketing medical products or may be a small agressive company exhibiting
innovative behavior but lacking relevant experience.
The relative importance of and role played by each participant is
dependent. in any specific case. on the "technological gap" between that
participant and the technology being transferred. It is the role of the
Biomedical Applications Team to recognize the strengths and weaknesses of
each participant and to supply the motivation. competence. and institutional
linkages to ensure success. Tie methodology of the Biomedical Applications
Team as presented in section 2.2 addresses these factors.
Technolog y will be interpreted throughout this report as including
all of the skills, techniques, and understanding as well as the materials.
devices, and hardware that make up a specific technology. 8
 Technology
transfer as used throughout this report will refer specifically to horizontal
technology transfer. That is, the transfer of technology from one
situational context -- the one for which the technol o kty was originally
developed -- to another situational conte.t.g This transfer will normally
ORiGWAL PACE iS
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result in some modification of either the technology or to the situational
context to which it is transferred.
Ruttan and Hayami have defined three levels at which technology
transfer can occur. These levels are:10
Level is Material Technology Transfer. This involves the
transfer of hardware from one situational context to another.
Level 2: Design Technology Transfer. In this case both
hardware and software may be transferred for the purpose of
imitating the original technology with some modifications for
a new application.
Level 3: Capacity Technology Transfer. This level involves
the transfer of knowledge and ability so that the recipient
can generate his own technology.
In medical technology transfer, there are few instances in which a level 1
material transfer will occur. The transfer of physiological electrodes
developed for use in space vehicles, to use in clinical medicine represents
a level 1 transfer. Most medical technology transfers are level 	 and
level 3 transfers. The redesign of an aerospace component or system for
application in medicine constitutes a level 2 transfer. The utilization
of NASA-generated knowledge, techniques, and procedures in the
development and design of a new medical product constitutes a level
transfer.
'.3 Biomedical Applications Team Methodology
As noted in the Introduction, and indicated in figure 3, the
activities of the Biomedical Applications Team can be separated into four
phases. Within each of these phases of the program. the specific ittions
and responsibilities of the team are, to a certain extent, fixed. However,
team methodology incorporates flexihilit^ that allows it to respond
appropriately to the specific c:harac:te ri%tics of particular technolotfv
transfer cases.
14
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SCREENING
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IMPLEMENTATION
AND
MONITORING
Figure 3. Phases of RTI Fiomedical Appl nations Team Activit,- .
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The identification of technology transfer opportunities
involves: (1) the identification of a medical problem or need; and,
(2) the identification of relevant aerospace technology that solves the
medical problem or satisfies the medical need.
The identification of medical problems occurs through the direct
interaction between a team member and a researcher or physician within a
medical institution. At present, the RTI team interacts directly with
medical staff at 27 medical institutions throughout the eastern United
States. These insitutions are listed in table 1.
A study of medical technology transfer by the National Academy of
Engineering and funded by NASA has concluded that the recipient must take
the lead in defining medical problems. 
11 
This is consistent with the
experience of the RTI team. As a result, the Biomedical Applications Team
emphasizes obtaining complete and extensive descriptions of medical
problems and needs from the medical researcher or clinician who is referred
to as the problem originator or recipient.
Certain medical institutions and medical professionals are more
innovative than others. 12 Research has shown that the first hospitals
to adopt innovation are generally large medical centers or teaching
hospitals geographically close to the place where the technology was
developed. Further, those hospitals with highly trained medical staff
tend to be more innovative. The "innovative elite" in medicine generally
act to improve the quality of health care rather than to achieve maximum
economic efficiency. Finally, once a hospital has adopted an innovation,
the widespread use of that innovation is enhanced if the innovating hospital
interacts frequently with other medical institutions. The Biomedical
Applications Team takes into account these factors concerning innovative
behavior of the medical community in its problem identification activities.
As noted above, innovative physicians emphasize quality of health
care to a greater extent than achieving maximum economic efficiency.
There is ample indication that medical technology introduced in the past
10 to 20 years often has tended to increase the sophistication of medical
diagnosis and treatment, but, has not contributed to i reduction in the cost
16
of health care nor to increasing the quality of health care for the pop-
ulation as a whole. 13 This indicates that there is an opportunity for
introducing aerospace technology in a manner to reduce the cost of
health care or at least assist in containing health care costs. The
efforts of the Biomedical Applications Team are directed toward
identifying opportunities that potentially reduce or contain medical
costs.
Technology relevant to medical problems and needs is identified
by a variety of techniques. Once a medical problem or need is specified,
a computerized information search of the aerospace literature is per-
formed by one of the six Industrial Applications Centers (IACs). The
RTI team utilizes the services of the IAC located in Research Triangle
Park, North Carolina -- the North Carolina Science and Technology
Research Center. These computerized information searches can identify
information on potentially relevant technologies.
An additional approach to identifying aerospace technology is the
circulation of '-roblem Statements to NASA Field Centers. Individual
medical problems are concisely described in Problem Statements. Each
Problem Statement is sent to NASA engineers and scientists working in
areas related to the medical problem. Responses to Problem Statements
fro g, these engineers and scientists can lead to the identification of
tecnnological solutions.
Finally, the Biomedical Applications Team frequency contacts NASA
scientists and engineers known by the team to have a strong interest in
transferring technology to medicine. This is the most direct, efficient,
and rapid approach to locatin, technology.
A medical problem in combination with a potentially relevant
aerospace technology constitutes an opportunity for technology transfer.
Tne next phase of the program is the investigation of factors that
determine which opportunities are most likely to be successful.
i"n
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Effective screening of opportunities enables the RTI
Biomedical Applications Team to focus on those opportunities with the
most promise for successful medical solutions and commercial products.
In order to continue work on a particular opportunity, the team must
determine that most of the following requirements are satisfied:
The solution improves medical treatment or diagnosis
or reduces the cost of health care;
The solution is recognized by a medical mission agency
and the medical community as a contribution to improved
health care;
• The solution incorporates NASA technology or
expertise;
• The market for the new or improved product justifies the
required capital investment and production cost to the
manufacturer;
• A manufacturer can be offered protection either by
exclusive license or lead time to allow sudden entry of
the product in;.o the medical market;
• The solution represents a discrete, well defined
transfer of technology involving limited research and
develo, ,nrent effort; and,
• Candidate manufacturers with the required marketing
and production capabilities have e\Dressed an interest
in commercialization.
These factors are evaluated by rvvie.v of thy , biomedical literature.
market surveys, interview,. witrm indListr r •opre"entatives, and
discussions with appropriate nw di(al stat ► . Am n of the data collected in
18
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this process is used in the development of commercialization strategies
as described in the next section. 	
L
2.2.3 Development of Strategies
The development of strategy for successful technology
t ransfer must take into account product development and marketing,
clinical trials, acceptance by the medical profession, and identification
of funding sources for the various tasks involved. With emphasis on
obtaining commmercialization of NASA technology, strat?gi ps must involve
obtaining industry participation.
The previously mentioned National Academy of Engineering study of
medical technology transfer reached some important conclusions concerning
strategy for technology transfer. 
11 
Successful technology transfer requires
intimate and significant involvement of both the donor and recipient
throughout the transfer p rocess. Further, the involvement of industry
throughout the transfer process is essential. Finally, the manner in
which new technology is introduced to the medical field is a critical
factor •
 in its success; the new or improved product must be accepted by and
applied by the medical community.
The experience of the RTI Biomedical Applications Team has confirmed
these conclusions and expanded upon tnem. 	 Industry must be involved
throughout the transfer process and must be brought into that process as
early as is possible.	 Further, the involvement of industry will qenerally
require some rreans for giving a specific manufacturer a proprietary
position. This may involve either an exclusive license or sudden entry of
the new or improved product in-() the medical market.	 Industry will view
new product opportunities from the outside as being in competition with
its own internally generated product ideas. This means tnat opportunities
for technolog y transfer generated through the Biomedical Applications Team
Program will have to compete for industry capital and management attention.
The acceptance of a new product by the medical community involves d
fairly specific sequence of events. Fo Howing development of the product
it must be subjected, in gener,+l, tr clinical trials. 	 This muwt be followed
Cr' " F AL PACE (S
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by publication of the results by a recognized medical expert. Generally,
the product must be exhibited at medical meetings. This sequence of
events normally leads to physician acceptance.
Medical marketing and distribution frequently are not an integral func-
tion of medical product manufacturing firms. Thus, in addition to select-
ing and obtaining the participation of a medical product manufacturer,
the team must also identify and bring into the transfer process an organiza-
tion havin g the capability to market and distribute those products.
Each specific opportunity for medical technology transfer will offer
a new scat of barriers and strategic options. Thus, the forma-
tion of strategy is riot a repeatable and specific activity.	 It is in
itself a problem solving effort. The most important common feature of
strategy form.,tion is thoroughness. All contingencies must be anticipated.
2.2.4 lmplenrentation and Monitoring
Experience in the implementation of strategy has shown
that the chance for- successful technology transfer is increased by active
involventE^nt of the Biomedical .Applications Team throughout the transfer
process. By monitoring and coordinating the activities of the participants, 	 I
minor problems can he prevented from becoming major obstacles.
Reports and documentation are an integral part of the team methodology;
they are involved throughout the technology transfer process. Implementa-
tion of strategy is nu exception .  periodic status reports are issued
inf,rr •mally to keep all participants informed. 	 Upon completion of the
transfer prok'ess, the team prepares a tec111101 ► Lty transfer report documenting
all important aspec ts of the transfer process. sections 3.0 and 4.0 of
this report present dokullientatior; on completed technology transfers and
•. t,r tus reportN on .r 1 1 ac t i vr- t t'Chrn0l00a ' t.ranS f0r • i dSeS .
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3.0 TECHNOLOGY TRANSFERS
During the reporting period, seven technology transfers i
completed. Two of the seven transfers involved the incorpora
NASA technology in commercially available medical products:
a Cardiology Teaching Manikin, and NCI-14, Containers for ttaititaimistj
Drugs at Low Temperature during Shipment. The remaining five are
institutional technology transfers. Two of the institutional transfers
(CP-3, Clinical Information System, and UNC-89, Protein Separation)
have long term potential for conmercialization.
These seven transfers are documented in the following pages. The
medical applications, NASA technologies, the transfer process, and major
participants are identified.
PROBLEM VAM-32: Cardiology Information Presenta-
tion Techniques
Education of medical students in cardiology requires access to
patients having a variety of specific forms of heart disease. Bringing
together- the student, instructor, and patient is an expensive, time
consuming process that does not benefit the patient. An alternate approach
is for the student to observe and work with a lifelii,e manikin that
simulates heart disease.
Or. Michael S. Gordon of the l;niversity of Miami Medical Scnooi
started developing a manikin that simulated a single disease state over
ten years ago. He began work on a multiple disease state inanikin in 1969.
As the number of disease states being simulated increased, the quantity of
visual information and data that roust oe presented to the student increased
significantly.	 This information,wnich must be presorted visually, inclines
patient histories, electrocardiograms, X-rays, hemodynamic data, and
responses to medical and surgical treatments. Gordon was concerned with
the quality of the visual presentation of this supplemental information.
The visual presentation techniques used in conjunction with the cranikin
should allow effective and Efficient transfer of information to the student.
CF PCUIJ QUA:.:—,Y
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The Biomedical Applications Team determined that NASA studies of
techniques for effective visual presentation of data were directly
applicable to the presentation of information to medical students. 	 In
its early investigation of this medical requirement, the team determined
that Gordon's manikin was far superior to other commercially available
medical manikins.
	
It simulated a larger number of disease states with
greater realism. Also, it was easier to use and was highly reliable.
Finally, team interviews with cardiologists at other medical schools in-
dicated that G01-doll's nU► nikin nret their rvquirements.
The Biomedical Applications Team, in searching the NASA technical
literature, identified studies of vitival infornkrtion presentation tech-
niques performed at NASA's Kennedy Space Center (KSC). Mr. S. A.
DeMars who had been involved in this NASA study met with the chief
engineer of the manikin project, Mr. D. Patterson, aril the Director of
Instructional ZeSM11'CeS for, the University of 'Miami, Mr. John Fisk.
Samples of 35 nrrn color- slides to be used with the manikin system were
studied and dlSCLIssed. Mr. Demars noted that the NASA studies were
relevant to the manikin information presentation system and that the
manikin presentation could be improved considerably. Working relationships
were established between KSC. the University of Miami, and the manikin
project staff. KSC sta f f made many recommendations regarding color and
format and reconwiendations concerning information content of slides to
be used with the manikin. 	 Incorporation of NASA-developed concepts into
the slide presentation was initiated tw KSC staff and completed by the
medical coinnunications staff of the University of Miami.
They now konwiercially available cardiology teaching manikin illustrated
in f igure 4, wf • ich simulates 40 disease st,ites incorporates NASA visual
presentation concepts throughout the information presentation proeiram.
This s y stcm. manufactured by Messrnore and Damon in New Vor • k. was recently
jud,ted the hest medical exhibit at the Annual Meetintt of the American
College of CardierlOkly.
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PROULM NCI-14: Therlrlal Prutection for Drug
Shipments
The National Cancer Institute (NCI) slakes about 250 shipm>cnts per
month of heat-labile drugs to locations in the U.S, and about hO ship-
ments per month to foreign countr es. Most of the drugs shipped are in
Ilowderfornl and packaged in sealed sterilized glass injection vials.
Each shipment typically contains from 1`5 to 1ht1 vials.
Hie tenllu`rature of these drugs must be mainta1tied at tlr below 55'F
during shipment and delivery, i.v.. a period up to 74 hours, The re-
quired period of tin ge. the low heat. capacity of the materials comprising
a drug shipment, and site and weight limitations imposed by air shipment
make this a difficult problem.
The Biomedical Applications Team identified this problem through
discussions with the Nil chief pharmwcist who is reponsible for proper
Itackaaintl of drwl shiptilent.s to locations throughout the world.	 'he NCi
I'v+111 ,011lents and Slnlple shippin g containers were submitted to NASA's
Langley Research Center (LRC) engineers for study and recommendations
con:ernintl advquate packa g ing concepts for heat-labile drugs. LRC
te%t% inditatrd that NC, drug containers used at that time did not allow
adequate thern1,11 prote:tion of drugs. They made a number of r•econrllenda-
tl.I ll. relateo to an improved --ontainer : ( 1) The at-Y ice used previously
tit NC I Ila-, inNufficient ttlerlMl Capacity and ShOUld 0C i't.'plaCed b1 Wdtel -
iCc'. (%) The ice should be frozen in flat plastic bags placed around the
sUr • fa^e of tilt` pahka ge ,Is 01 1 pOSed to belil g placed ill i l ly celltel , of
tr.e dru g ;ontainrr • .	 (t) At lt , ast two inches of riolded pol^atyre`le or
uret l l,rnr team insulation shoul.l he pla yed on all six sides of the shipment
;,)rltal tit , t•.	 1 . 1	 Use as many airtl,l l lt vapor seals as possit , le In the
.`a,k,l g in g iolitl,luration.	 The NASA-developed ,lulIt0d AIU110 Ill :e,t Illylar.
s1100ts would he .+upropr' iate for these seals.
While t.hi was investioa; ing this problem, NCI requested Harr y Diamond
aht^ ► at,^rit^s to test thell , old nkithod of drug paekagin 'l.	 Results of
,est% ,It and recolllllt ' ildatIoils made tiv Ilar'r • 	 0laliltl r d t.abor • atorles were con-
-'INN 1 111 With tt`at rt``ults ' 111,1 reionnlrnd,ltlnn. fr m NASA.	 The results of
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both NASA's study and that at Harry Diamond Laboratories were incorporated
into the specification of a new packaging container for the delivery of
heat-labile drugs. Within the last year, NCI has contracted with a
company in the Silver Springs, MD area for containers for shipment of
drugs from the NCI pharmacy.
PROBLEM CP-3: Automated Measurement from
Coronary Angiograms
The utilization of NASA technology has aided Dr. C. F. Starmer and
his colleagues at the Duke University Medical Center in developing the
Duke Cardiovascular Data Bank. This data bank documents their clinical
experience with more than 4,000 patients with suspected and confirmed
ischemic heart disease; it is used to augment their ability to diagnose
and treat such patients. All data are stored in a computerized informa-
tion system that allows the physician to recall historical data and
related information on patients with medical profiles similar to that of
a new patient. Prognostic information based on similar experience is
available for each new patient both in video and printed laboratory report
from. This data bank is proving to be an effective clinical tool for
providing medical care.
Numerous problems had to be solved to develop this clinical informa-
tion system. Two of the more difficult problems required that Dr. Starmer
and his group develop: (1) an input mechanism for graphic data that was
easy to use and would aid in grouping patient data according to patient
characteristics; and (2) a data storage system that would facilitate the
use of accumulated data to develop meaningful prognoses. Solutions to
these problems were aided significantly by the utilization of computerized
image processing techniques developed by the Jet Propulsion Laboratory (JPL).
The existence of this NASA technology was brought to Dr. Starmer's
attention in 1969 by a member of the RTI biomedical Applications Team.
Through his continued interaction v,ith the team, Dr. Starmer received a
suiruner fellowship at JPL in 1970. During that training period, he mastered
many of NASA's image processing tochniq ue^s. The ,,.e techniques have become a
vital part of the data system.
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Although we have classified this application of NASA technology
as an institutional transfer, it does have commercial potential. The
magnitude of this potential will become clear as more clinical experience
is gained. A second data bank system is currently being installed in
the Harvard School of Public Health; it is expected to provide some of
this clinical experience. The team will continue to monitor this effort.
PROBLEM DU-97: A Compact, Highly Sensitive
Light Detection System
X-ray diffraction is a powerful biomedical research technique for
determining the orientation and spacing of macromolecular subunits of
biological tissues. The diffraction pattern is usually recorded on a
photographic emulsion that has a glass plate as its backing. The optical
density data of the diffraction pattern are read from the plate by an
optical densitometer. A microscope objective lens focuses on the emulsion
side of the back-lighted plate as the plate is mechanically moved back
and forth. The light beam that passes through the emulsion is less than
100 microns in diameter. However, when the diffraction pattern is very
faint, the densitometer scanning unit cannot produce satisfactory results
due to low contrast between exposed and unexposed emulsion.
An alternative optical scanning technique can be used to read weak
diffraction patterns. This method uses a stationary, slit of light about
100 microns wide and one centimeter long. The plate is moved mechanically
so that the slit sweeps out a repetitive raster pattern. The light
passing through the plate is collected and refocused to a point by an
elliptical front-surface mirror. At the focal point, the light modulates
a photodetecto . The output of the detector is sampled by an analog-to-
digital converter and input to a minicomputer. The computer is programmed
to process the data into a format consisting of a matrix of optical density
values.
The researcher constructed a mechanical scanninq device and optical
system but found that the allotted space for the photodetector was very
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limited. He requested help in designing a photodetector that would per-
form satisfactorily and fit into the system.
Because of the very restricted space available for the detection
system, a photomultiplier detector could not be used. Instead, a photo-
transistor or photodiode appeared more appropriate. The NASA literature
was surveyed and a phototransistor, the photo-FET, was identified as a
solution. This device is as sensitive as a photomultiplier tube, when
rated by output microamperes of current per microwatt of input light.
The team worked with the researcher in designing an operational
amplifier circuit to interface with the photo-FET. Both the sensor and
the amplifier circuitry were fitted into the case that holds the objective
lens of the microscope. This system was placed in operation and has per-
fornied satisfactori 1-y.
PROBLEM MISC-47: Miniaturized Tension Measur-
ing System
The problem originator contacted Mr. John Santos at Langley Research
Center (LRC) regarding a technical problem being encountered in a cardio-
vascular physiology research project. Mr. Samos and a team member visited
the problem originator- and received a thorough explanation of the problem
and research into the response of vascular smooth muscle to various stimuli.
Smooth muscle is ant of the several types of muscle tissue found in
the budy.	 It is usually found in the walls of hollow organs and in the
walls of blood vessels.	 It is known that vascular smooth muscle responds
with contraction or- relaxation under various stimuli. 	 To stud y these
response patterns and other' mechanical characteristics, a techniques has 	 I
oeen developed which uses small lengths of isolated blood vessels. These
i
lengths of vessel are formed into loops and hooked over two prongs on a
holder. The distance between the prongs is increased incrementally and
with each incrememental increase, the tension developed by the muscle is
measured. In some experimental preparation,, the loop is suspended in a
solution and muscle tension is measured.
A preliminary problem statement was prepared by the team. Mr. Samos
and a team member discussed the problem statenk^nt with an LRC engineer,
t. i'GUK Q...
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Mr. John D. Thompson. who has extensive experience in the development of
miniaturized electromechanical instrumentation for NASA applications.
The problem originator visited LRC and met with Mr. Thompson to discuss a
proposed solution. Mr. Thompson fabricated the miniaturized holder and
tension measuring device. Upon completion of the device, Mr. Thompson
visited the problem originator's laboratory and installed the holder and
measuring system; the device has functioned satisfacturily.
This successful application of NASA technology has advanced progress	 \
in this cardiovascular research project by at least t, months. A savings
in both time and uruney has resulted.
PRoBLLM ZINC -89: 	 Protein Separation
It has been hypothesized that growth hor7rrone:' from the anterior
pituitary gland causes bone tWOWth by stimulating the production of the
protein somatomedin which then serves as the active growth agent. The
isolation and identification of soir ►atomedin has been hindered by three
factor-,: (1) nr reservoir organ is known from which relativel y
 large
quantities of the protein may be extracted; (2) somatomedin, t ►ierefore.
rnust be isolated from blood, where it is present in very small ." .dntities;
and (3) identification of the amines acid sequence of the protein requires
a hianly purified extract.
The problem ori g inator, Dr. Judson Van WYk of the University of worth
Carolina at Chapel hill, had successfully isolated a few hundred milligrams
of the purified protein through a l engthy and costly procedure requiring
several tens of blood. An improvement in the efficiency of the isolation
process was rlc` ^ded to obtain a sufficient quantity of pure soma toriedin
to detvey:rrne its amino acii composition and sequence.
Personnel in the Marshall ^, ►iace Flittht Center (MSFC) Technolo,j% , tilization
Office reviewed the problem SLatc'nk'nt. They suggested that ;he team con-
tact Dr. flier of the L i nive.'rsity of Ari:ona.	 hr. Bier has worked closely
with	 in the development of new vleetrophore'sis techniques that utili :e'
the low- g ravit y environme-It of *0,rb. Or. H er. Dr. Van W y k, and ,+ tram
member dis.ussed the y p roject in dvt.r ► 1 .rnl agreed to undertake .r .ollabor • a-
tive effort to define a technique for IN01,+t ing pure Somatol ►redin r101•e
effi;iently.
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Dr. Van Wyk forwarded to Dr. Bier carefully prepared samples.
Ur. Bier used NASA-developed techniques and instrumentation to accurately
identify key isoelectric potentials. With this information, Ur. Van
Wyk was able to improve the separation process. Their success thus far
has nkide possible the sequencing of many of the 66 amino acids comprising
the protein, resulting in significant savings in time on this research
project.
PROBLEM VAM-21: Contour Mappinq of Head
Surgical techniques to repair severe congenital facial dbnornrdlities
have been developed. They involve sectijning of the skull and relocating
and reshaping various facial featureN (e.g., nose, mouth, eye sockets).
Patients who previously were distioured hopelessly new have hope for a
reasonabl Y normal life.	 I
Contour maps of the front, rear • , side and top views of the human head
are used to determine the best surgical procedure aria to monitor the
recovery process. These maps are obtained using standard ster•eophotographic
techniques. Stereophotographic pairs are made of each view and analyzed
usin g a stereo plotter.	 Through analysis of these data. c ► • itical volumes
and surface areas are computed and primary landmarks are located in
three-dimensional space. Unfortunately, stereophotogranrnetry. especially
using the stereo plotter, is slow and expensive. Better techniques to
produce and analyze the data are needed.
Ur. )cram N'Aimovsky reported that a system for extracting three
dimensional measurements from a pair of stereo images had been developed at
the .let Propulsion Laboratory iJPL) .ind that this system could be modified
to meet the pro b lem ori,jinator's requirement,. Yakimovsky discussed with
the problem oriUirlator' tole feasibility of adaotin,l the JPL to accurately
locating kov anatomical points in three dimensional space. The problem
,)r • iginator agreed to supply stereo pairs in the form of glass plate
negati,es that 11,1,1 been p reviously	 u,in.l ,te^re, ophototirannit-tl.v to
Yaklmovskv for anal•!iis.
C"	 J
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Yakimovsky performed the analyses and docume,,ted the results in:
Three Dimensional Measurement and Display System for Assisting Diagnoses
of Craniofacial Abnormality. Results of Yakimovsky's analysis compared
favorably with the results obtained using stereophotogrammetry.
This transfer of NASA technology makes possible the development of a
more effective tool for the study and treatment of craniofacial abnormali-
ties. The resulting system can simplify the process of obtairing three
dimensional descriptions of objects such as the head.	 In addition, the
NASA-developed interactive analytical system can give the physician more
flexibility in analyzing patients.
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4.0 STATUS OF ACTIVE TRANSFER CASES
The Biomedical Applications Team is investigating 28 transfer
cases at p-esent. These 2.8 cases include 13 medical problems identified
prio- to 1 January 1977 and 15 new problems identified during the report-
ing period.
Of the 28 active transfer cases, all but two have the potential
for becoming commercialization technology transfers. This represents a
significant change in the character of the problems investigated by the
RTI team when compared to problems investigated in previous years. The
change is a direct result of emphasis on the potential for commercializa-
tion in the team's identification of opportunities and screening
activities as described in section 2.0.
As noted in the preceding, 15 new problems were identified during
the reporting period. Problem statements describing these new problems
are presented in Appendix B. The team has identified potential solutions
for 11 of these problems. The status of those new problems for which
potential solutions have been identified is reported in this section.
Four of the transfer cases categorized as active problems have been
reported as institutional technology transfers either in this report or
in previous final reports. 3 In tnese instances, the team has recognized
opportunities for commercialization transfers, and is taking appropriate
action. Problems in this category are:
DLi-1•:	 Testing of Neuropathic r?tients
MISC-37	 Weight Alleviation Device
WCI-4	 Controlled Rate of Freezinq a Liquid
WF-56
	 Pressure Transducer Calibrator
Jet Propulsion Laboratory staff are entirely responsible for the progress
;:lade in moving this case toward commercialization.
(""MAI PACE Ia
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PROBLEM DU-14: Testing of Neuropathic Patients
The neuropathic patient testing s ystem has been reported previ-
ously as an institutional transfer 3. The team has evaluated the po-
tential market for the system for testing neuropathic patients. It has
been determined that the potential market has two major sectors: insti-
tutional and noninstitutional. The private practitioner composes the
noninstitutional sector. From interviews with physicians, research
personnel, and manufacturers, it was determined that the private practi-
tioner would not purchase a testing device similar to the neurological
tester, because both doctor and patient are concerned only with gross
changes in behavior which can easily be observed.	 In addition, less con-
cern exists over an incorrect diagnosis here than in the hospital environ-
ment.
The institutional sector of the market was found to have two parts.
The firs, is a group of about 50 to 100 physicians doing research on
Parkinson's Disease and related neurological disorders. This market,
nowever, is not large enougr *o cover product development and marketing
p osts. The second part of the institutional market involves use of the
Jevice as a diagnostic tool. Every hospital with a neurology department
is a potential customer.	 The utility of the device in this application,
however, has riot been established. As a result of discussions with
pnysicians in the fiela, a one year p roject to establish this utility has
been specified. Patients in several different disease groups and control
groups would be tested. One disease group would include those with
Parkinson's and other related diseases. Another would include psychotic
patients that are being treated oitn drugs that induce Parkinsonian
behavior. The experiments would be designed on a sound statistical basis
and would involve well over a nundred patients. To accomplish this study,
the design of the neuropatnic tester- would have to be upgraded and a new
unit fabricated.
A manufacturer has been identified who is interest in collaboratinu
in this market-development project. The nidnu`acturer met with his board
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of directors and obtained their approval of participating in this project.
The board also authorized the expenditure of the necessary manhours and
development funds, confirmed by a letter to this effect from the manufac-
turer to the RTI team. According to the agreement, an engineer from the
company will work closely with NASA and team personnel to finalize the
design and ensure that it can be manufactured. Once a design is agreed
upon, the manufacturer will repackage the device and make it available
to the research market. His entrance into the diagnostic market will
depend upon verification that the device meets the medical need for
diagnosis.
PROBLEM DU-98: Di g ital TV Display Device
A ubiquitous instrument in basic medical research laboratories is
the cathode ray oscilloscope. However, the basic oscilloscope cannot
display effectively waveforms that change very slowly or that are due to
single, transient events. No basic oscilloscopes can produce a permanent
record of the displayed waveform, and such a record (paper copy) often
is needed for the lauoratory notebook. rrequently, the instrumentation
funds are not adequate to support the purchase of specialized oscilloscopes
that can do one or more of the above special tasks. The RTI team defined
the specific needs for oscilloscopes and searched the NASA literature for
applicable instrumentation or expertise.
The digital instrumentation grout) at the NASA Lanc , ;i, ,
 Research Center
proposed several items of tecr.!ology for the solution to the need for an
adaptable, low cost, oscilloscope. 	 The "digital TV display device" is art
instrument utilizing a unique combination of digital data manipulation tech-
nology and analog television display technology. The TV display device has
oeen constructed as a wire-wrap prototvpe (fig. 5) and its capabilities
have been demonstrated.
Several prospective manufacturers have been sent information describ-
ing the TV display device. One company responded with such enthusiasm
that the team loaned the prototype to them for quick verification of the
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potential of the device. Because this company already manufactures and
sells analog and digital instrumentation, the TV display device would
seem to be a logical extension of the product line. At the present time
there is no known impediment to the acceptance of the TV display device
by this prospective manufacturer. The team will work closely with the
manufacturer to develop and lmplenlem nt the nkirketinq strategy. Because
of the manufacturer's established market position, this device might
berollie Conrlke rcialIV available in 1978.
E'ROBLi M 1111-99: V-slotted Head Screws
the problem 01 • itlinator described the dittILulty of adjustlny orthotic
braces when they are tie 1 d together w1th screws. When loosening these	 I
screw: to make brace adjustllk'nts, tale screwdriver • often Cants taut of the
st. rew he,1d 'Ind dest ro y s it.	 the manufacturer must drill out the screw,
retai l the brace, and then make the necessary adjustment.. What should
hive been ,i 3- or 1-minute job turns into a 30- or 40-minute ,lob. V-slotted-
nead screws have be,n designed sperifiidlly to eliminate this problem,
IN, team obtained several samples of different sized V-slotted-head
sc row . and delivered thelll to the t t l • t1 bIVI II Orlt1inator.	 He ,'tlr •eed to evaluate
tileset screws in the ,ittu.11 m,+nutatturiny environment. 	 Depending on his
results, other prosthetic and ortliot ic shops maY be included in an expanded
studs from which put)ll,ations ran result.	 This will conclude they first
llm1lor ste t In ,1 market deVeloi t llk'llt protil"Im for the !) c -1'ewti.
l'ht1GLLM LKI-1 :	 Inlh 'oved 010CS for Vi tr'eCt0111V Surtie ►_y
wring vitrectomy eye surgery, the surkleon's visualization of the
Vitreous hulikir lira ►' the retina requi res placement of a contact lens or
ions tiirror System oil tllt` to1'ne,i anti the u se of an operating microscopy
1111f01'ttln,ltelV, IVdll,iblt' lens system~ tit, 110t itrtrvide a satisfactory view
of t ile V It 1'eoUS 11111101'. 	 1 hey irt, vi t her too bill kv of too i imi ted in the 	 11'
t'ieid o1 view.	 the pi'oblt-m orltim,itor i, intt rusted in improvin,i these
Out ica 1 "'ys teals (of , v i t r''t t rimy surgery.
t^Nk;liV^ 
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Suggested solutions to this problem are being evaluated. A manufac-
turer who currently markets a surgical kit for vitrectomy surgery has
been identified for contact in the event a NASA contribution to this
important problem is found.
PROBLEM GCCC-1: A Teletype Machine Test Unit
A profoundly deaf person needs to be able to use the telephone system,
but cannot unless special equipment is available. Most important is the
need to summon emergency services (fire, police, and rescue). To alleviate
this problem, the Sertoma Club (a civic club) has instituted a program in
North Carolina (and elsewhere) to equip emergency services communications
centers in each city with Teletype (TTY) machines and to equip the homes
of all the deaf of the city with a TTY set. Each TTY is interfaced to the
phone system by an acoustic coupler. A state-wide telephone directory lists
the phone numbers of all holders of such TTY equipment. Such a directory
enables the deaf to use the TTY for nonemergency purposes, such as
communicating informally with other deaf individuals. Nationwide, there
are more than 12,000 such installations in homes of the deaf and their
hearing friends.
Virtually all of the TTY machines in the program in North Carolina
are model 15 machines that were obtained when the news wire services changed
to new and faster TTY printers. These TTY machines are unreliable, require
frequent maintenance, and are not particularly desirable because they use
the old 5-bit Baudot TTY code instead of the modern ASCII code. While in
many communities the deaf have a local serviceman to maintain these
machines, upkeep is a major problem. As a result, a request was made to
the team for	 device that could be used by the field repairman to
facilitate troubleshooting and adjusting the TTY machines.
A digital communications engineer at the Langley Research Center,
who has design experience with CMOS digital integrated circuitry, suggested
an integrated circuit signal generator as a means of solving the TTY repair-
man's need. Following this suggestion a wire-wrap p rototype device was
constructed. This test set (figure 6 ) generates the TTY machine code for
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the test character pair "RY" in sufficient repetitions to fill a full
line of TTY text, followed by the carriage-return and line-feed characters.
These machine code patterns are available as contact closures of a :Wd
relay of* as audio tones. The audio tones are used to test the acoustic
phone coupler while the relay contacts Wray be connected in series with
the local loop of the TTY selector magnets or keyboard meLhanism,
Tne TTY siqnal generator shows promise as a commercial device. The
device has been demonstrated to a West Coast electronics company ill the
last two months and the biuteprint of the device has been submitted to
another West Coast company to determine their interest in imnufacturing it.
currently the prototype is being evaluated by a field TTY repairman.
This field test will be concluded at the end of January 1978. The report
of the evaluation will he included in the descriptive literature that is
being prepared by the team as Dart of the conmerciali:ation procedure,
PR061 iM GCCC
	
SCA Receiver for the Handicapped
In 1975 the Federal Collllnunications Conrnission g ranted pemission for
the use of audio machine code progranrning on the SCA (Subsidary Comnunicrtion
•1utI100ty) Subcarrler of contrlercial iM radio stations. Organizations for
the deaf ,lee interested in utili:inv the SCA subcarrier for the transmission
of Radio TeletYpe (RTTY) programs in lartl.,e urban areas. The audio tones
that comprise the RTTY transmissions art,
 exactly the same tones that are,
aeneratee d and decoded by the phone couplers that are already widely used by
the deai fol . telephone Comllunit:atiOn by Teletype. All that is needed for
thes e 11011lee s to be ahie to receive the RTTY bre laticasts is the ad,lition of an
Slit subcal'1'1eI ,
 1'eCee lveI , at each Nlte.
	
The SCA ,ut i carrier receivers now
avallable MV t00 t:OStly fur larkre scale PLO'Chase!S by the .leaf,
ut 1 l 1 :1 m; [ 1 hast- l e e l Aee d- 1 oop teehno l o.1y a ellal livers at the itoddard
Space Fli.tht Center have designed and guilt a Circuit board that enables
a low govt• conwnee rciallY available FM radio to receive the SCA RTTY broad-
Casts,	 0 1 1 November a, a team 11101h0' %1.l tt'd 6100 i,ll'd aml piCkt1 d up this
radio and took it to the Philadelwiia .ire,i f i l l , a field test.	 The FM station
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of Temple University. in downtown Philadelphia. broadcasts SCA RTTY twice
daily t ronl pru(t ► • anrlri ng nla teri d 1 provided by the Pennsylvania School for
the Deat. This RTTY syste.nl is the first, and at the present time, the only
RTTY system for the deaf ill
	 United States. These RTTY broadcasts are
received by nkire than 30 deaf families ill the Greater Ue l aware Vd I l t'v area.
More than 300 families will eventually be equipped with SCA receivers in
this area. In the Philadelphia test of the NASA SCA receiver, the reception
was satisfactor y with the set at a distance of 111 milt's from the transmitter
site, even thou gh the set wati equipped only with a whip antenna. This range
,huuld be nit l re than doublod when the re'ceive'r is attached to a properly
oriented. directiun,ll TV ur FM antenna.
There are several reasons why nkore hl1Y systems for the deaf do not
exist ill
	
United Mates. tine is that the equipping of many homes of
t
i
lt.' Beat with SCA ;ubcdr• rie'r receivers has heen rather expensive. The NASA-
de eloped SCA subc arri er receiver can perhaps de'nxinN t rate a method whereby
tilt' cost of such receivers can be reduced.	 Till` team is identifvin q
 a
manufacturer for the .Inuit boards and an ele''ctronics firm to install
the boards. oil 	 contract basis, for organizations of tree deaf who are
interested in initiating SCA RTTY transmission s y stems in tither connunities.
PROBLEM LSD-1 : New Method for Cleaning Tenth
•1 neiv method for cleanillo teeth has been proposed by NASA personnel.
This I:It'tnrd consists of couplin g
 ultrasonic energy into a writer jet.	 Dr.
Josepn Heyman at LanQley Research Center. ill 	 ill 	 ultrasound,
e\ p ressed 1 ntores t ill Working of this problem. However. tie was concerned
* 01 3t thV t'llt`1'gy 10 elS lleceSSal'\ to ITI1OVe 	 WoUld damage both tht` glllrlS
an-, t'it, teeth.	 helievill.t that ,1 Very effective teeth CleaninQ $YSt011 Could
oe? aevelopVd usin,l ul t ►'a50und, Ile propoSed a SySteil 1'e401-01 '1 eery lo ►%
efler,l) levels. Ourin g the past year the' toam identified a manufdeture ►' that
tvas	 interested in pursuing development of this system. This manufacturer
1. .nc of the world's lar•tte,t producers tit toOthbrushes, and such ,1 device
ill,, not
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vwould meet an immediate new product need. Currently the team is attempt-
ing to have a NASA patent application initiated, which must be done if
this commercial opportunity is to be pursued.
PROBLEM MCV-3: Determination of Deltopectoral Flap
Viability
Wounds too extensive to heal by suturing may be closed by skin grafts
or skin flaps. A skin flap consists of skin and subcutaneous tissue that
is moved from one part of the body to another with an attachment to the
body being maintained for nourishment. Uften, with cancer in the throat
region, large areas must be dissected. A flap from the shoulder and upper
chest (deltopectoral flap) is commonly used to cover the head and neck
defects after surgery. The clinical problem with this flap is that its
survival is unpredictable (5':.• to 20`, sustain necrosis). A method to
determine accuratel y the viability of a flap could direct treatments to
enhance flap survival.
The Jet Propulsion Laboratory (JPL) has proposed a solution for pre-
diction of flap survival using computerized image processing of photographs
in the visible and infrared portions of the spectrum. Dr. Victor Anselmo
of JPL has suggested visiting the problem originator at Medical College
of Virginia to take photographs of flaps for analysis at JPL. This applica-
tion is tieing evaluated by the RTI team for clinical feasibility and
conrne rc i a l potential.
PROBLEM "-1CV-4:
	 Sealing of Amputation Sturrp
tieuroma to Prevent Pain
The end of a severed nerve often develops a bulb or swelling called a
neuroma which is hypersensitive to pressure or traction. A neuroma repre-
sents a distorted portion of the injured nerve in which regeneratin g
 axons
have escaped the normal perineural barrier to grow in a disorderly fashion.
tieurumas which form in amputation ;tiwips are particularly painful because
they ociupy an unprotected position at the new extremity where they are
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subject to repeated blows, pressure and irritation. The amputee is often
incapacitated by severe pain, and, in these cases, the constant use of
pain killing drugs can lead to drug addiction. Attempts to prevent neuroma
formation fail if they injure the perineural seal which functions normally
to present an effective barrier to diffuse axon growth. A successful
remedy must provide an effective, permanent seal of the severed nerve
without injury to the perineurium.
An important potential solution to this problem was found when the
RTI team translated papers from the 1969 Innsbruch Conference on Kunstoffe
in der Chirurgie (Plastics in Surgery). Kotter reported that in his nerve
repair work, he discovered inadvertently that certain cyanoacrylates
effectively prevent nerve regeneration. The problem originator is anxious
to test this tissue adhesive in the prevention of neuromas. The RTI team
is working with the problem originator, industry, and chemists at Langley
to identify the specific cyanoacrylate best suited for this application.
PROBLEM MCV-5: Lung Sound Modeling
Disabling pulmonary illnesses may result from a variety of causes
including environmental factors, pulmonary vascular pathology, asthma,
and c y stic fibrosis. Researchers have examined the structure and function
of the normal lung as well as the mechanisms by which alterations in a
respiratory function may lead to disease. In many pulmonary diseases,
especially lung cancer, early detection and accurate diagnosis can enhance
the success of the treatment.
Dr. J. Hardin of the Acoustics Division at Langley Research Center
is working with the problem originator to employ sound analysis techniques,
lun.l airflow parameters, and a lung model to determine the location and
nature of the alterations in lung structure responsible for compromised
lung function.
OR!^S" V
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PROBLEM MISC-37: Weight Alleviation Device
The weight alleviation device has been evaluated at the Mississippi
Rehabilitation Center. Evaluation results demonstrated that this NASA-
developed system solved a significant medical need. Although the evalua-
tion indicated that the device required extensive modifications, it also
demonstrated that a definite market exists for the device.
The device was returned to Langley Research Center (LRC). Dr.
Clingman and a team member visited LRC during mid-July and met with the
problem originator and the engineering staff there. This group discussed
the desired modifications including modifications required by a potential
manufacturer. A complete redesign was required, but the NASA-developed
concept of the weight support mechanism would be retained. Complying
with suggested design criteria, the engineering staff at LRC developed
several novel designs. They were reviewed by Lire problem originator and
the potential manufacturer. While the problem originator suggested only
minor changes, the manufacturer- saw major manufacturing cost difficulties
with the designs.
	
In effect, a production engineering effort was required
that was bevond the experience of either the manufacturer or the NASA
enaineerin,^ croup. The team is exploring several possible avenues to ob-
tainin g this production engineering effort. When the effort is completed,
the team can finalize the commercialization strategy that has already been
partially completed.
Jr. Clingman has arranged for the manufacturer to take the re-
designed weight support mechanism developed at LRC. ►} rou s t it in a frame,
and add all required harnesses. At that point the system will be made
available for evaluation in a therapeutic environnwnt. 	 This evaluation
must be a structured program, the results of which must be published by a
physical therapist. More than one evaluation is highly desirable. This
tvve of evaluation is necessary beLduse Vie market for this device does
not exist and must be developed.
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PROBLEM MISC-48: A Simple, Presettable
Torque, Brake System
Exercise machines are typically used by more than one person. It
is desirable that the braking system of such d machine allow a desired
work load to he set by each person who uses the machine. Also, because
exercise regimens are often prescribed by a physician, the braking device
of the exercise n ►achine must he calibrated in units of hrakinq torque.
	 1
Unfortunately, currently dvailabiV methods for , nreetinq these requirements
are costly.
A manufacturer of an exercise machine described to Dr. W. H.
Clintiman of W. H. Clingman and Co.. the need for a low cost, presettable
brake. Dr. Clingman, who was visitinq the manufacturer in conjunction
with the development of conrrrercialization strategy for another ,
 team project,
relaved the requirement to the team. In response, the team conducted a
NASA literature search ano discussed the problem with a NASA contract
engineer. It was concluded that the classic "prony brake" system had many
of the features of the desired brake system. The prony brake is a rather
simple capstan device ill 	 braking torque is delivered to a rotating
I
drum sur • fdce. With such a bi ,aj e, (he torque call
	 preset rather accurately
I
a
.^
 nreasurin q the tension exerted oil
	 entrance and exit wraps of the
`
	
	 brake's belt. Both tensions can be adjusted so that the desired braking
torque is applied to the rotating drum.
With this information, the team was able to rapidly respond to the
request. A report describing the solution and a su ggested design was
prepared and forwarded to the rr , nufdcture ►'. At the present time, the
company is in the process of fabricating sevel . ,11 prototypes of all ever-cise
machine that incorporates a prony h ►•ake. They will be placed in hospitals
and rehabilitation centers for clinical evaluation.
PROBLEM M13- C -49: Alicrowave lherinography
COM01,ti0nal	 them:rograt , hyat lntrarrd tretluenCres
	 (--IOGH_).	 a tool
in	 Lne detection of	 breast Cancer for man gy Ve,rl'S.	 ran detect
	
thermal p ro-
files
	
at	 the	 skin's	 surface only. A method for vreclse measureme nt of
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subsurface temperatures is required for the safe, effective application
of hyperthermia to cancer treatment. A number of studies have shown
that hyperthermia in the range of 42% to 43°C is synergistic with
radiation therapy in the induction of tumor regressions. To prevent
destruction of normal tissue, however, the subsurface increase in
temperature must be carefully monitored.
Microwave thermography is a low frequency analog of infrared
thermography. A shift to lower frequencies permits the detection of
thermal profiles at depths of up to several cm below the body's surface.
Langley Research Center (LRC) is working with Eastern Virginia Medical
School and the Medical College of Virginia in a project to study the
use of microwave focusing to induce local subsurface hyperthermia and
to measure the resulting temperature changes. The RTI team will attend
a hyperthermia conference to be held at LRC in January, 1978.
PROBLEM MISC-50: Advanced Rugged Hearing
Aid for Children
There are 200,000 or more children in the United States who have a
sufficient hearing loss to interfere with normal acquisition of speech
and la-iguage.	 Fortunately, most of these children do have some useful
hearing remaining; for such children the hearing aid remains the primary
device for compensating the hear i ng loss. Since a hearing loss of even
a moderate level, if uncompensated, seriousl y interferes with the normal
acquisition of speech and langua ge and therefore has profound educational
implications, the early fitting and consistent use of a proper hearing
aid is one of the most essential elements if the child is to succeed in
the hearing world.
So far as level of physical activity is concerned, a child who wears
a hearing aid is no different from any other healthy child. Specifically,
a hearin g aid worn b y a child will be subjected to suostantial shock,
vibration, and occasionally iru^^r• sion in water.	 Th,it hearing aids presently
dvall,ible for children are indde-ludte to withstand these environmental
stresses is well demonstrated by studies of hearing impaired children
which show that typically one-third to one-half the hearing aids that
these children wear are not working properly at any one time. A major
redesign of the hearing aid for children with emphasis on making the aid
as child proof as practicable is clearly in order.
The bureau of Education of the Handicapped approached NASA Head-
quarterF concerning this need. In response, the team prepared a problem
statement in July 1977 for NASA Headquarters to distribute to the Field
Cen ers. Several responses were received. The tears will work with Head-
quarters in the evaluation of the proposals.
PROBLEM NCI-4: Controlled Rate of Freezing
a Liquid
The treatment of several forms of cancer and cartain other diseases
involves the infusion of large quantities of stem ceils or other blood
components (e.g., red cells, white cells). To obtain the necessary
quantities, the cells are collected, frozen, and stored for later use.
Unfortunately, many of the cells are damaged by the traditional freezing
process. Some authorities have suggested that a nonlinear rate of freezing
is the damage mechanism.
Jet Propulsion Laboratory (JPL) personnel suggested a technique which
would detect the onset of freezing and then would increase the neat transfer
rate during the release of latent heat so that a nearly constant rate of
freezing would be maintained from room temperature to -50°C. Goddard Space
Flight Center (GSFC) personnel 'eveloped the JPL suggestion into hardware
using cornputer analysis techniques developed for such space applications as
ensuring the thermal balance in spacecraft. The completed freezing system
was tested at the National Cancer Institute with excellent results.
JPL entered into a contract with a large connercial organization
to develop the new freezing technique into a conmer •cial system for pre-
serving red cells. Work on the contract began in too spring of 1977, and
the commercial organization is very pleased with progress. The team will
continue to monitor the development of this cornrnercial pro-luct and provide
assistance to the JPL effort a c appropriate.
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PROBLEM UMISS-5: Leg Brace Weight Problem
While NASA has demonstrated the feasibility of the use of composite
materials in orthotics, more appropriate applications must be identlH ed,
and manufacturing techniques that are practical for use in the orthotic
shop must be developed. A plan to accomplish this was submitted to NASA
in October 1975, and an RTOP based on this proposal was submitted by
Langley Research Center (LRC) in March 1976 and subsequently was approved.
A major rehabilitation center has received a contract from LRC to demonstrate
applications in rehabilitation. The problem originator, a materials expert
who is familiar with composites, is the director of engineering at the
rehabilitation center. He visited LRC in July 1977 for one week of train-
ing in the use of composite materials. During that visit, the team met
with the problem originator and Mr. John Samos, the Technology Utilization
Officer, and discussed the objectives and strategy of the contract.
Several possible applications of composites were also explored at V is
meeting.
The problem originator has procured the necessary equipment -^
materials and has installed and tested the equipment. He and his colleagues
have identified a simple but promising application and are developing the
appropriate manufacturing technique. The resulting item could be produced
in quantity and commercially distributed to other prosthetics and orthotics
shops. Dr. Clingman is exploring several possible marketing strategies
and has met with potential distributors. One distributor is interested in
working with the team to move composites into the rehabilitation market.
PROBLEM UDC-83: Neonate Thermal Control
for Use in Surgery
The need for a neonate thermal control system was presented to the
RTI team by Dr. E. N. Kraybill of the Neonatology Department of the North
Carolina Meworial Hospital. Neonates (infants up to 4 weeks o' age) often
exper i ence a marked fall in body temperature during anesthesia and surgery.
f)HIG NAL FAGF, IS
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This hypothermia causes respiratory depression and mad result in cardiac
and circulatory failure. Neat loss by an infant during X-ray and
catheterization procedures presents the same hazards as anesthesia and
surgery; regulation of body temperature is especially difficult for the
premature infant. Further, heart and neural tube defects, which account
for one-third of all major congenital defects, often, require cardiac
surgery during the neonate period. The prognosis for neonate cardiac
surgery is enhanced by a care fully monitored and controlled cooling of
the infant.
A need exists, therefore, for a method both to warm and to cool
the neonate during surgical, X-ray and catheterization procedures. Current
efforts to meet this need include heated operating tables, elevated room
temperature and radiant heating. These techni ques suffer the disadvantages
of nonuniform heating, uncomfortable conditions for the surgical team,
and lack of capability to cool as well as heat the neonate.
Dr. Bill Williams of .Ames Research Center responded to the RTI
problem statement with the suggestion that the liquid-cooled garments
designed for astronaut thermal protection could be modif4ea fo:- this applica-
tion.	 Incorporating design features to obtain o p timal surgical access,
flexibility and neat exchange characteristics, a neonate prototype is now
ready for surgical testing. The RTI team will continue working closely
with Dr. hraybill in this initial evaluation stage.
The commercialization stra^egy for the neonate suit was developed
during the tear's verification of the need for a neonate thermal control
system. Through interviews w4th anesthesiologists and neonatologists at
NIH and medical centers, it became appa rent that designing a liquid-
circulating neonate garment to be compotible with existing hospital hvpo-
hyperthermia pumping units would have the following advantages:
(a) Greater willingness of physicians to use the garmen-,
as a result of the low initial equiprient investment.
Surqeons could use the pumping units already available
in their departments for initial trials.
	 Investment
0. :
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in a unit dedicated to neonate surgery would be
necessary only after demonstration of the tech-
nique's efficacy.
(b) Greater confidence of physicians in the technique
as a result of using familiar, trusted equipment.
An important factor in this confidence is the
physician's knowledge that the hospital electronics
personnel have shown themselves capable of repair-
ing the existing pumping units.
Inforrrration packages including selected articles from the medical
literature and a description cf the NASA-neonate suit were sent to the
three major manufacturers of hypo-hyperthermia pumping units. The
enthusiastic response to this package led to plans by RTI team and Mr.
Herb Holley of the Ames Technology Utilization Office for a commercializa-
tion meeting to be held at Ames in March 1978. At this meeting, all of
the liquid-circulating garment applications will be reviewed for the
potential manufacturers.
PROBLEM UNC-90: Electromagnetic Flowmeter Calibrator
Studies show that variations in the shape of the blood flow pulses
are good indicators of the condition of the cardiovascular system.	 In
order to measure the pertinent variations, a flowmeter must have a
frequency response curve that is flat from 0 to nearly 100 Hz. Electro-
magnet,c flowmeters, which are the most widely used instrument to measure
blood flow, generally meet these requirements, but an effective method for
dynamically cal orating them does not exist.
A problem statement was prepared and distributed in 1976. No
solution was found. Recently the team received a new inquiry for su--h a
device. This reflects a growing interest in the clinical importance of
the dynamic characteristics of blood f?ow. As a result the team is re-
considering this problem, but, if a brief solution search is unproductive,
the problem will be inactivated.
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PROBLEM ZINC- 91: Prosthetic Urinary Sphincter
An estimated •1 million people in the United States suffer urinary
incontinence from a variety of etiologies. includintl multiple sclerosis.
.11111,11 turd injuries. cerebrovascular disease. birth defects. diabetes
Ilk' IIitus. .Anil 1% a surgical tongtlication resuItiny from prostatectunly
t ,torts to restore Contlllelltt , have included electrical stimulation.
operative u1 • lnal'y divt, ► 'sion. eltter11al tAlection, and implantation of
prosthetic devices, (hose attempts have thus far yielded unsatisfactory
results for 011t , 01' more of tilt , tollowintt rt,asorls:	 (1) decrenw'nt of
nlusclr rr.i,on'.e tivt'r tiler; (2) surtmAl t:omplerity anti attendant risk,
0) unsultahi1ity for use by hush males Mid tt'm.11rs. and (4) lack of
I t at (tilt Control, (lilt , v01'v I 1 1"011li$ing solut I 'm to this Ilroblenl is a
prosttlettic sphincter designed b y Ors. Scott, ltradley, anti Tin11n (see fi^lur'e 7 ),
illk I'rr^thetic sphincter'. which is commercially available. is a fluid
s "tt,nl with ,1 rt,st,rvoil' located ill tilt, andonit'll and two operator bulbs to
coil t ro I t ilt ,
 tIow. Wht,n the fluid is trans furred tr'om the reservoir to
tilt , tuff at'ound the urethra at tilt , netlt of tilt' Madder. urine flow is
1 1 1 , 1 1 vt,ntt'd by tilt , urethl • al occlusion.	 During voldirn1. the fluid is
transferred Nick to tilt , rt,at'rvoil'. thus de flatin kl the cuff and allowing
urine thew throutlh the open uretiir,I. This system has the advantages
of (1) providin ') voluntal'^ r\ternal Control of hlatidt'r' funt'tlon and
(.') el imin. 111,1 t i lt , urinary tt'-Wt illfeCOO11 prohlt,nl that results from a
continuall y opt'n urethra with coll c-tant urine drippintl. Success with this
1 0011110m , Ilas heel( 1 11111 t etl 'IN a rt'-,lll t of :
(l) 1t,a00t , 11'11111 tu0intl, rt''t,I' M I', ta i' i11ft;
(^^	 ( t 1111111 111,11 itill, t (till,
(;) overpre " "41 hint( tilt' guff with rt''ultln,l
urethr,l l t iwit ,
 nt,t r'asis; and
(41 comltle\it y of tilt , inillantatit'll ^ur,1t'ry.
illt` prot'It,111 01'l,lll1Ator, Or. I't'tor Steven N of tilt` North Caro Iillm
NY 11 lo Hai I it ,
 NI I it.11 1 1 1'o10Q lit , IMvt lilt' iIt. Cu t ltlt tetl tII,1I ,1 `i Jill IIifit,d. lilt) I't
rt, li at , It` I , ros tilt,
 t I 	 I'll illt tv1 would he of ,tt'eat t ,e lit , fit i11 the nhlnQvIlt'nt
of tll'ilkerl incolit111enie,	 •1 review of tilt ,
 llk'dit,ll 1itel'aturt , cUntirult'd
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Dr. Stevens' description of the problem. A problem statement was written
by the RTI BATeam and distributed to every NASA field center.
Mr. Ray Helms and Mr. Harold Smyly of Marshall Space Flight Center,
who have been involved in the development of miniaturized valves, responded
to the RTI problem statement with several designs for a prosthetic
sphincter. All of the suggested systems eliminate the abdominal reservoir
and reduce the number of operator bulbs to one (see figure 8). In
addition, the valve employed in the new sphincter design is based on a
NASA-developed miniaturized ball valve in which NASA introduced the use
of a sapphire ball instead of a stainless steel ball. Sapphire can be
polished to a finer finish than stainless steel and, therefore, is better
suited for use in "zero" leakage, high reliability valves than is stain-
less steel. Thus, the major advantages of these new prosthetic sphincter
designs are:	 (1) minimum surgery for implantation; and (2) simplicity and
improved miniaturized valves for maximum reliability.
The Helms/Smyly designs were reviewed by the following individuals:
(1) Dr. L. Keith Lloyd
Department of Urology	 Ci,,! 7NAL Q ^r —T IS
Spain Rehabilitation Center
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University of Alabama
Birmingham, AL
(2) Mr. Joseph Traub
Director of Rehabilitation Engineering
Rehabilitation Services Administration
Washington, DC
(3) Dr. Anton J. Beuschen
Director, Division of Urology
University Meoical Center
Birmingham, AL
(a) Dr. Peter- Stevens
Director of Pediatric 'Urology
School of Medicine
University of North Carolina
Chapel Hill, NC
(5)	 Dr. Gerald Timrn
Vice President
American Medical Systems, Inc.
Minneapolis, MN
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(6) Dr. Russel Fine
Director of Research
Rehabilitation and Training Center	 ORIGINAL PAGE IS
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Birmingham, AL
Each of the reviewers concluded that the NASA zohincter designs showed enough
potential for success to warrant further design and prototype development
work by NASA.
Medical device manufacturers were asked to submit proposals for a
joint NASA-industry effort to fabricate and test these sphincter designs.
This early involvement by industry is important to the successful solution
of the incontinence problem. Review by the manufacturer's engineering
and medical personnel will provide additional information on the viability
of the proposed NASA solution. Early involvement by the manufacturer can
ensure adequate support for the required animal and clinical trials. The
capability of the manufacturer to build and market the resulting product
will ensure commercial availability of the sphincter for all patients in
need of this device.
	
It is planned that a team of NASA personnel, urologists,
and the RTI team will evaluate the proposal in February 1978.
PROBLEM VAM-17: Optical Profilometer
4 machine tool company identified by Dr. Clinqman is interested in
developing the optical profilometer for use in quality control of a
machining process. The company is waiting for the team to determine the
capability of the device.
Tne team used the device to measure several known surfaces. In
November 1977, the resulting 3-dimensional information was forwarded to
the problem originator for analysis. Unfortunately, the results from this
analysis suggest that the device is not applicable to the machining problem,
but the analyses results are compatible with the application planned by
the problem originator. 	 In this application, the device will be the data
collection instruwrrent for an international consortium that is dedicated
ti the treatment and study. of-cleft palate
	
Modifications of the device
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will be required. The depth, range, and speed of operation must be in-
creased, and a simple method for identifying specific surface areas must be
developed. The team is working closely with engineering personnel at
Langley Research Center and the University of Miami to determine if
these modifications can be made within established cost constraints.
PROBLEM WF-56: Pressure Transducer Calibrator
Personnel from the Fabrication Division at Langley Research
Center repaired the pressure transducer calibrator. Dr. Clingman delivered
the repaired device to a major manufacturer of pressure transducers for
their evaluation. 	 In his discussions with officers of that company, he
learned that users of pressure transducers are becoming more sophisticated
in checking and calibrating their transducers including catheter transducer
assemblies. Although the potential market for this device as a calibrator
remains very small, a related clinical application appears to have a much
broader market. Dr. Clingman has arranged with this manufacturer and
several hospitals to explore the clinical application. 	 First, the
►anufacturer will run a technical evaluation. 	 Based on the positive results
from tnis evaluation, Dr. Clingman will arrange the clinical evaluations.
Tneso evaluations are the initial steps in the commercialization strategy
for this device.
PROBLEM WF-123: Tool for Fusing Surgical Suture Knots
Artificial monofilament fibers, such as polypropylene, are currently
in wide use as surgical suture material for suturing the skin of humans.
Tnese fibers are very difficult to tie into secure, non-slip knots.
	
The
problem has been described in various medical journals. The common solution
seems to be the practice of tying five and six repetitive knots on top of
each other. Because this is a time consuming process that extends the
dLO-dtion of surgery , a need exists for a method of more rapidly securing
the surgical filaments emanating from the first basic knot tied by the
surgeon.
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The team has contacted engineers at both the Langley Field Center
and the Marshall Space Flight Center (MSFC). In particular, the inquiry
at MSFC was directed to engineers who had reported in the NASA literature
a technique of ultrasonic welding of thin plastic matetrial to metals.
However, it appears that the technology is not applicaole to the suture
problem.
During these conversations, several alternative techniques were
suggested. One envisioned the possible use of a tool, similar to a
wire-:,trap tool, to wrap the loose ends of the suture thread about a tiny
plastic bobbin hav',,ty protrusions similar to Velcro fasteners. These
suggestions are being pursued.
PROBLEM WF-124: Upgrading of Performance of the Tracheal
Stethoscope for Reliable Respiration and
Heart Rate Monitoring During Surgery
The tracheal stethoscope is a device that can be u,ed b y an
anesthesiologist during surgery to monitor vital signs of the surgical
patient. By listening to the sounds conducted through the stethoscope,
the anesthesiologist can determine the heart rate and breathing rate of the
patient. Although, using the stethoscope for several hours is an arduous
task for the anesthesiologist, the stethoscope remains a simple, reliable,
and useful instrument. The suggestion has been made that the acoustic
signals detected by the tracheal stethoscope could be routed to an electronic
signal processing device. The device could be programmed to automatically
display both the neart rate and the breathing rate of the surgical patient.
To determine whether such an automatic analysis is feasible, the
acoustic processing laboratory at Langley Research Center, which has every
modern device for acuustic signal processing, is being utilized. 	 Personnel
at this lab are being provided with tape recordings originating from the
tracheal stetnoscope during surgery. They are attempting to identify
several acoustic frequency bands that can be used as distinctive signals of
the heart rate or the respiration rate. If such unique frequency bands can
be identified, the electronic processing circuitry can be designed to
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segregate the sounds from the tracheal stethoscope, process these acoustic
signals, and display the heart and respiration rates. At the present
time, the acoustic processing of the tape recordings is still in progress.
PROBLEM WWRC-18: Female Incontinence
Urinary incontinence is a frequent disorder that can result from
spinal injuries, neurogenic bladder disease, multiple sclerosis, cerebral
	 I\
palsy, prostrate surgery, stroke, and nonspecific etiologies, especially
in the elderly. The current method for managing a large number of
in:ontinent malES involves the use of an external roll-on rubber cuff and
a collection bag attached to the leg. This closed collection system
solves many social and health problems resulting from exposure of the urine
to the air and the skin. A successful closed collection system for
females is not available. Incontinent females, therefore, are managed
by diaper and pads or by catheterization.
The RTI team is currently collaborating with Mr. Roger Michaud at
Johnson Space Center (JSC) to evaluate the female urine collection system
developed at JSC. Sizing parameters are being determined for prototype
fabrication in early 1978.	 Involvement by medical device manufacturers
awaits a feasibility study and patent clarification.
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During the reporting period, two commercial technology transfers
and five institutional technology transfers were completed. Twenty-six
of 28 currently active transfer cases have the potential or introducing
new or improved commercial, medical products incorporating NASA tech-
nology. These numbers reflect the emphasis in the RTI Biomedical Applica-
tions Team program on transferring technology by the introduction of
conrrercially available medical products. It is through this commercializa-
tion of NASA technological solutions that widespread utilization is
achieved. To better accomplish this goal, the team has studied in depth
the technology transfer process within the context of the medical field.
The insights gained from this study and from the team's experience
have resulted in the team's present methodology. By adapting its
methodology to the requirements for commercialization, the team is increas-
ing its effectiveness and efficiency in converting medical problems and
needs to commercial solutions based on aerospace technology. The team
concentrates on medical problems that are perceived as problems by a
significant fraction of the medical community and on obtaining the
participation of the medical manufacturing industry throughout the tech-
nology transfer process. The addition of a management and marketing
consultant to the RTI team has significantly enhanced the team's under-
standin q of the n*dical manufacturing industry and how to interact with
`	 that industry.
Problem solving activities during the reporting period have involved
i
all NASA Field Centers. This broad interaction between the team and NASA
scientists and engineers engaged in a broad spectrum of activities has
been an essential part of the identification of technologies relevant to
E
	
	 medical problems. By the combined use of NASA computer information
searches and direct contacts with field center staff, the team has been
able to identify the most approvriate aerospace technology for- solving
specific medical problems.
Team experience has demon`tr,rted that interactions with medical
mission agencies is important to the Biomedical Applications Team program.
The expertise and experience tit the medical and enqineerinq staffs of
57
these agencies in specific medical areas can assist the team in validating
the importance of specific medical needs. In addition, the support by
these agencies of the objectives in particular transfer cases can be
of assistance in the commercialization process. The RTI team has worked
extensively with mission agencies by participating in a number of work-
shops and by consulting with individuals on specific transfer cases.
Perhaps the most important lesson that can be derived from the team's
experience in working with medical manufacturers is that technology
transfer in medicine is extremely complex. The barriers to technology
transfer are numerous and include the characteristics of medical device
Ill. rnufacniror ,., uw^dii.iI imrrkeIinq di%trihutinn Ioracti ► (	 acceptan(r of a
new product by the medical community, and all the well-known barriers to
technology transfer in general and not peculiar to the medical field.
The team's better understanding of medical manufacturing, marketing, and
distribution has enhanced its ability to form successful co.in ►ercialization
strategies. However, there is still much to be learned concerning this
aspect of medical tecnnology transfer and the team will continue and
expand its interactions with the medical industry in order to gain this
understanding. Of most importance in this area are ways of effectively
nanulina patents and licensing agreements. More generally, all aspects of
government-industr y interfaces must be understood arid facilitated.
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PROBLEM NUMBER
CM-1
DIX-1
DU-99
DU-100
ERI-1
GCCC-1
GCCC-2
GCCC-3
MISC-48
MISC-49
MISC-50
MISC-51
TU-43
UGA-1
WF-126
PROBLEM TITLE
A Miniatur-,zed Constant Rate Infusion Pump
Horizontal Shower
V-Slotted Head Screws
Vaginal 'licosal Blood Flog
Improvea Opt^.cs for Vitreetorq4 Surgery
Teletype Tester
SCA Reccivtr for the Handicapped
TTY %C-,b,,2r.1 Test Device
Simi Z' Pres t `. zt Ze Torq.ce Brake 5 b stem
Microwa c : her7o raph-,
aearir.7 Ai' for Chi Zdrer.
aY:Str'C^P ►::_.','..O': f?r Acoustic seta Z Acsess~ier`
I-7 anC Oxt/ger.
.^croscZ : ^_ci^:.z-:^ ►: Systa►^
?ressurc .^ * -a euremert
a
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PROBLEMS INACTIVATED
PROBLEM NUMBER PROBLEM TITLE
p(J-94 X-Ray Screens
DU-96 Source of 7600°A Monochromatic Light
DU-97 A Compact, Highly Sensitive Light Detection
System
EU-23 Miniature Telemetry Unity for Monitoring EMG
EU-24 1iniature Telemetry Unit for use as a Therapeutic
Tool to Control Spasticity
JEF-2 Electronic Instrumentation for Detectinc andfying Motior- in CZosed Circu i :w'uanti
Ti:.-tures
JEF-3 CeveZozment of a ,Miniature, portabZE, :`tZti-
Cranne? Biofeedback Avraratus
MISC -47 ':ir.iaturized Tension !•.'easurin^ S;,;ster~
'•I1SC-51 nsti*.. ,entation for .4coustic Fet1: 	 s. aaa • ent
NCI -14 ?z-kin.7 Des° V:n for The y"a:	 antr::' M-7
: ,-me ►:ts
TE-1 An	 ve"hoc: for Ap,)Z: ,in 	?rC3 %:Ji'	 -oatipy-S',..i.ation Detect:rs
TU -43 u•^n^- Ier^• '1^nit ,, o* ICE .;ra vwygef-
UCP-1 ^:.•Gr:'.'	 ;,^.•.,.,^41:: 'c'.t2:ors 	 .=ystew
UG."Pk -1 nerosol	 :':;:	 `'r.;'.'o :	 S;^s:e^
Uh!, SS-6
UNC -73
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PROBLEM NUMBER	 PROBLEM TITLE	 Z
UNC-87 	 Quadrupole Akes Spectrometer
UNC-88	 Improved Cooling Technique
UNC-89	 Protein Separation	
-	
I
i
UNC-92	 Method for Analyzing Video Tape Record
i
VAM-24	 Processing of Fapid MicrofZuorimetry Data
VAM-25	 Mecnari-,aL-Energ.o Storage Device for Hip
Di cart i cu la t ion
VAM-27	 Contour , ,L-Tning of Head
VAM-33
	
Breast :arcer Screenin g: Technique
VAM-34	 :'eorate E:ie Tracker
WF-121
	
	 Accurate `1easurerent of Inritt and Output
from 11 trisor. is Probes
WF-125
	
E10.laation or =erro,raz:retie Fluids
WF-126	 Intra--rani Flu..,,; Yri:ssure I.Vasurwrert:
j
I^
i
l
I
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ACTIVE PROBLEMS AS OF DECEMBER 31. 1971
PROBLEM NUMBER PROBLEM TITLE
CM-1 A Miniaturized Constant Rate Infusion Pwnp
DIX-1 HorisontaZ Shower
DU-74 Testin.7 of Neurnrlthic Patie+!ts
DU -98 ?igi tal TV-Displad Devic c
DU-99 l'-Slotted Head Screws
DU-100 I'a?inal AlucosaZ Blood FZow
ERI-1 i--roved Optics for Vi*recto^! • Sur,ler,.
GCCC-1 lelet,,,pe Tester
GCCC-2 SG'A Receiver for the Hand_*czr-e;
GCCC-3 Ke?boars Test Device
LSD-1 for CZeanin: ^ee:;:
b -3 of De ltorec"!• :: -:.,-
MCV-4 ScaZ:.).. of .4 v utation Sturm
	 tc Prevent Pain
MISC -37 Devicc
M:SC-48
_:^-:e 1!resettable Tor7ue "+•.::^	 s-^-
III SC-49 ' •ro.• ::+t :1.e!*^,^,,raphu
t1ISC- 50 f:earin,
	A-
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UMISS-5 Le,:	 ::•.:.•,	 a'e`,^I;t
	 ?roble!r
UNC -90 D'tct!• ••::.n:•'tic F'otv7eter
URIC-91 ..	 .. '.•	 ;'_^^=r,,:r,•
	 Srh' ►:ata+•
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WWRC -18
PROBLEM TITLE
Optical Profilometer
Pressure Transducer Calibrator
A tool for Rapidly Fusing Surgical Suture Knots
Upgrading of Performance of the Tracheal
Stethoscope for Reliable Respiration and Heart
Rate Monitor,na During Surgery
Female Incontinence
PROBLEM NUMBER
VAM-17
WF-56
WF-123
WF-124
A-9
APPENDIX B
PROBLEM STATEMENTS
PROBLEM DDH-1
HORIZONTAL SHOWER
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DATE OF PREPARATION:	 December 21, 1977
INSTITUTION:	 Dorothea Dix Hospital
Raleigh, N.C.
PROBLEM ORIGINATOR:	 Dr. Harold Glascock, Jr.
BATEAM PERSONNEL:	 Ms. Doris Rouse
WHAT IS NEEDED:	 An effective, pleasant and safe bathing system for
bedfast patients.
BACKGROUND:	 A large number of institutionalized patients are unable to
bathe themselves. This population includes s p inal cord injury victims,
cerebral palsy patients, multiple sclerosis,:pina bifida, epileptic, and
spastic patients. The two methods most widely used to bathe these patients
are as follows: (a) sponge bath; and (b) tub bath by lowering patient on
a gurney transport system. The advantages and disadvantages of these
techniques are discussed below.
The major disadvantages of the sponge bath are the time factor and the level
of cleanliness. Hospitals estimate the administration of a sponge bath to
require fifteen to twenty minutes of staff time and to involve the risk of
staff injuries while turning the patient. Sponge baths do not ensure adequate
patient cleanliness for chronic use in the long term care facility. This is
especially true in the large number o f bedridden patients whc are incontinent
of urine and feces and who have decubitus ulcers. The primary advantage of
a sponge bath is that no special equipment is required.
The major disadvantages of the tub bath involve the current methods of trans-
port and immersion, the cleanliness of incontinent patients, and the staff
injuries resulting fror patient lifting and lowering. One common patient
transport method is the Hoyer hoist with a sling seat. This seat provides
no head or neck support for the patient in the bath and does not allow
thorough cleaning of the buttocks. The possibility of self contamination
with ,microorganisms is a seriou ,  disadvantage in the t1se of a tub bath with
incontinent patients.
	 'Nursing staff injuries related to patient bathing are
a serious problem. An investigation by the Swedish Planning and Rationali-
sation Institute of Hospital and Health Care showed 25 days in a single year
lost for four people due to backache in a hospital's central bath department.
A orimary advantage of the tub bath is the psychological benefit derived from
immersion in warm water.
According to the Aberdeen Formula, a method of determining nursing staff
re quirements used in Scotland, an acceptable standard of basic nutting care
for X1'1 helpless bedfast patients consists of bathing once daily.
	 Inadequate
staf`ing and inefficient, awkward bathing facilities result in patients
receiving only two baths per week in most long term care facilities. A more
ef f ic i ent, convenient bathing technique may increase bathinc frequency, and,
this. ir:prove patient cleanliness and health. A recentl y
 developed showering
s^s:e- 1 by Arjo of Sweden is the mo , t advanced system available today. This
^;- ;	 PRECEDMI I PAGI 0.4W N
system consists of a trolley/stretcher that is wheeled to the patient's
bedside where it is raised to the bed height by a hydraulic foot control.
The patient is then transferred to the trolley and wheeled to the bathroom.
The stretcher carrying the patient is then rolled onto a table which is
slowly lowered into a bath. Approximately twenty of these units are cur-
rently in use in this country. The disadvantages of this system are as
follows:
(a) Bathing, not showering system. As a result, patients that are
incontinent of feces must bathe in water contaminated by their
own fecal matter.
(b) No access to the buttocks or perineal area. Adequate washing in
these areas is essential for patients that are incontinent and
have decubitus ulcers. Adequate and frequent washing in these
areas may decrease the incidence of urinary tract infections.
(c) Lack of patient privacy while bathing.
Promised Technology
The technology presently being considered for improving the bathing system
is a modified version of the horizontal shower developed by NASA to deter-
mine the effects of prolonged bed rest. A description of this system before
modification for hospital use is found in the attached NASA Tech Brief
B73-10M from Ames Research Center. Advantages of the NASA horizontal
shower are as follows:
(a) Employs a trolley/stretcher that both transports the patient and
serves as a bed in this shower.	 This minimizes lifting of the
patient by the nursinq staff.
(b) Shower heads p rovide thorough washing without ex posing the
patient to his/her own waste water.
(c) Shower heads have inner rotatin q
 vanes which spin the water into
tiny droplets and produce a soft, dense full covera ge spray that
massages the body.
(d) Water tem perature is re g ulated to prevent patient scaldinq.
(e) The gu ► ney on which the patient is transported and Showered is
made o f
 a nylon web. This allows easy washing of the buttocks
and per i neal area by a shower head located below the ourney.
(f) The shower is enclosed, thus maintaining patient dignity and
orivacy during bathing.
Current Status:
A manufacturer of patient transport devicr5 is currently evaluatin g_ NASA's
proposed modified shower for market potential.
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TTY KEYBOARD TEST DEVICE	
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DATE OF PREPARATION:	 December 19, 1977
INSTITUTION:	 Guilford County Communication Center
for the Deaf, Greensboro, NC
PROBLEM ORIGINATOR:	 Ms. Marzi Maury, Director
BATEAM PERSONNEL:	 H. Clark Beall
WHAT IS NEEDED:	 A small portable test device to display TTY character bit
patterns in order to facilitate field repair.
BACKGROUND:	 Many of the deaf in the United States utilize a Teletype
machine (TTY) and acoustic coupler to communicate over the telephone. The
TTY that are typically used in these installations are the older 60 wpm
Baudot models.
Field servicemen have observed that the most frequent malfunction in the
Baudot machine is in the keyboard sending mechanism. Because this mechanism
is a rather complex device, consisting of mechanical levels, springs, and
electrical contacts, the proper adjustment is seldom achieved by a field
repairman. Usually, TTY keyboard adjustments are made by the repairman
until correct printing is achieved on the TTY machine. At this point, the
keyboard may be only marginally operational. However, this may be dis-
covered only later after frustrating attempts to communicate reliably with
other TTY installations.
What is needed for the field repairman is a battery operated, portable, test
device that can certify the operation of the keyboard sending mechanism.
What is envisioned is a device that can monitor the local loop current that
flows through the keyboard sending mechanism. As the sending mechanism
operates. the test device could monitor the direct current pulses flowing
in the line.
Because the seven-bit TTY machine code pattern for a single character is
completed in less than one fifth of a second, the test device should be able
to botn record this transient signal and then display the serial pattern of
current pulses so that the repairman can observe the sequence and dwell time
of each individual bit of the pattern. 	 It has been suggested that the com-
merciall y availatle 5 x - LED matrix be utilized as a low cost dis p lay, with
each o f the seven horizontal rows of the matrix representing the 22-millisecond
dwell time intervals of the seven bits of the Baudot TTY code.
The utility of the proposed test device would not be limited to the testing
of only the TTY keyboard. If the interface were properly designed, the
test device could be used to measure signal distortion at virtually any
site %ithin the send and receive local loop circuits.
B- 6
PROBLEM RTI/CM-1
A MINIATURIZED CONSTAN"i RATE INFUSION PUMP
DATE OF PREPARATION:	 September 19, 1977
INSTITUTION:	 Carnegie-Mellon Institute of Research
Pittsburgh, PA
PROBLEM ORIGINATOR:	 Mr. R. K. Olson
BATEAM PERSONNEL:	 Doris J. Rouse
WHAT IS NEEDED: A small, constant rate infusion pump to deliver ap-
proximately 6 ml. of a drug per twelve hour period. Punip must be ;mall
enough to be worn by ambulatory adults and children.
BAC', GROUND:	 The conventional unit dosage drug delivery techniques
(i.e., one tablet every 6 hours or an injection twice per day) are often
inefficient and undesirable as a result of side effects. These pulsed
delivery systems can result in an oscillation between toxic and sub-
therapeutic levels (Figs. 9 and 10). A constant infusion of a drug, however,
would result in a zero-order delivery and a steady therapeutic level.
Side effects, therefore, are minimized.
This factor becomes extremely important in disease states such as diabetes
which require daily injections of a drug for the lifetime of the patient.
Thalassemia (Cooley's anemia) is an inherited disorder in which there is
a deficient synthesis of globin chains of normal hemoglobin. Most children
with this disease need chronic blood transfusions to maintain an active
life. Accumulation of excess amounts of iron from these transfusions and
by increased intestinal absorption is a major problem in these children.
'he excess iron may be partially responsible for organ damage, particularly
to the heart, leading to complications of the disease and death from cardiac
failure. 1,2 Deferoxamine is a dru g that combines with the excess iron and
prevents its accumulation and harmful effects to some de q ree.	 Poor
absorption of this dru g in the stomach necessitates daily injections for
the lifetime of the thalassemia patient. As in the case of insulin, a
constant infus i on device >+ould provide a more ef f icient and safer method
for drug delivery of deferoxamine.
Current Dru Delivery Devices
Diffusion Devices: Several methods for the delivery of a drug from
resevoir at a p,-edeter-ined rate have been designed. Examples of some of
these s y stems are as folljws:
(1) Ca p sules of polymeric material filled with a solid or liquid
drug or with a sus pension or solution of a drug in a fluid, in
which the release of 	 nt is controlled by Fickian diffusion
through the capsule walls.
j2) A heterogeneous dispersion of particles of drug in a solid poly-
meric matrix, which c.an he either- biodegradable or non-biodegradable,
and which control: the release of drug by diffusion through the
matrix, by erosion of the matrix, or by a comb'.nation of a dif-
,usion ar,d eresion.4
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Most systems currently being explored control the release of the drug by
diffusion through a polymeric membrane. Alza Corporation has pioneered
this research and is currently demonstrating in clinical trials that intra-
uterine devices that release progesterone at low constant rates can provide
effective contraception for a year using the equivalent dosage of three oral
pills, thus minimizing side effects. Although these diffusion systems are
useful in long term delivery of low levels of drugs, they are not practical
for the delivery of 12 ml. per day as is required in the use of deferoxamine
to treat thalassemia.
A continuous long-term injector was developed by Rose and Nelson. a The
motive force of the injector dEpends on the osmotic pressure developed by
a saturated solution of Congo red against water. This solution is contained
in a partially collapsed rubber compartment and is separated from a second
water compartment by a semipermeable cellophon a membrane. By osmosis, water
moves into the Congo red solution and expands the rubber compartment. It is
this expansion which provides the mechanical force to eject the drug out of
the apparatus.
Syringe Infusion Pumps: Syringe infusion pumps worn externally are com-
monly used to deliver larger volumes at a constant rate. These have always
been toolarge and cumbersome for convenient, life-long use by ambulatory
patients .6,7 Researchers at the National Institute for Medical Research in
London have recently developed a portable arJ -eliable miniature syringe
pump called the Mill Hill infuser for cont-r,;,--.s administration of drugs
and hormones. $ This system is driven by a lead-screw and arm. A mercury
battery, with an operating life of at least twenty syrin ge loads, supplies
a ouartz-crystal-controlled oscillator and integrated circuit divider,
p rovidinq gating pulses every few seconds to enerqize a motor with integral
gearbox. After each activation the gate circuit is reset by a oulse derived
frog
 the output shaft. The overall dimensions are 30x7Oxl3Omm. and weighs
300c. A 2 ml. disposable ;Mastic syringe is positively locked to the drive
mechanism, but can be replaced quickly. Two models are designed for a 2 ml.
per S hours or 2 ml. per twenty-four hour delivery rate.
Although the Mill Hill infuser represents a significant advance over previous
models, a smaller pump that car operate with larger reservoir volumes is
needed for use with arbulatory patients, including children stricken with
Thalassemia. A pumping device with no moving parts that approaches the
size e° a cardiac pacemaker would significantly enhance the practicality of
usinc constant rate infusion devices. An energy source with a lonqer life-
tirie that meets the size constraints would also improve the acceptance of the
device by the medical community and the patient population.
Constraints and Specifications
.1)	 Flow Rate o f 6 m'l./12 firs.
	
Rate constant + 20`: maximum.
,') Small size.
	 Reservoir of 6 ml.	 Pump size approximately that
of a cardiac pacemaker. The device is required throuahout the
patient's life and will be worr y by infants.
A miniaturized, long tvrm enerity source for the ou:rp.
(Ftq	 QUALITY
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(4) Flow Resistance. The pressure head required is that associated
with subcutaneous infusion and will probably consist pre-
dominately of the resistance of the tubing and needle connecting
the patient to the drug supply. (Up to 50 p.s.i.)
(5) Operation. Simple for patient or non-medically trained assis-
tant to load and actuate. Must operate independent of patient's
position (horizontal, vertical).
(6) Durability. Rugged enough to permit relatively normal activity
by user.
(7) Tamper proof for use on infants.
Characteristics of Relevant Technology: NASA techniques and expertise in
t e sensitive delivery of fluids would be applicable to the solution of
this problem. The NASA technology in miniaturized, high reliability energy
sources may also transfer to this application.
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PROBLEM DU-100
VAGINAL MUCOSAL BLOOD FLOW
DATE OF PREPARATION: 	 September 6, 1977
INSTITUTION:	 Duke Univers'ty Medical Center
Durham, N.C.
PROBLEM ORIGINATOR:	 John F. Steege, M.D.
BATEAM PERSONNEL:	 Richard W. Scearce
WHAT IS NEEDED:	 A device is needed that is capable of remotely measuring
vaginal blood flow in the resting state in an office setting.
BACKGROUND:	 It is a common presumption that most sexual difficulties arise
from "psychological" causes, which in the experience of a sex therapist often
means that contributory physical or psychophysiologic components are either
overlooked or misunderstood. Meager knowledge of sexual psychophysiology
is often an obstacle in dealing with these problems.
Vaginal mucosal blood flow, observed qualitatively by Hasters and Johnsonl
to be a maJor pa;ameter in sexual response, has attracted considerable at-
tention duriiq t''.e past few years. Although some intriguing data have been
generated, methodoiogic and technical difficulties have prevented reliable
quantitative mEasurement.
A device is needed that is capable of remotely measuring vaginal blood flow.
it would prove invaluable in investigating physiologic vaginal changes
in response to "normal" events such as phases of the menstrual cycle, varia-
tions in menstrual cycle length, use of contraceptive hormones, variations
in sleep patterns, etc. Vaginal blood flow measurements might also prove
useful in measuring the pharmacologic side effects of widely used psycho-
tropic and antihypertensive drugs, topically and systemically administrated
anti-,liotics, chemotherapeutic agents, local and external beam irradiation,
etc. The rigor of the vaginal mucosa could also be evaluated before and
3* 1., er vaginal or abdominal surgery on the female reproductive tract and
bladder. Consistent data from studies of th^s kind would heln gynecologists
and =ar-ily physicians greatly in evaluating the psychophysiological components
Or se\;,al complaints. 	 In this circumstance there would be an obvious need
=or devices capable of measuring vaginal blood flow in the resting state in
ar o = =ice setting.
trevious Work
Several investigation$ nave used phetoplethysmographic devices to measure
va g inal blood flow. 2-i 	 it has not been possible to eliminate
seve ral important variables that most likely affect results with this
tecnnique, such as: (movement of the measuring device along the longi-
'udin3i axis of the vagina; (3) variation ;n the extincticn coefficient
of Fed oglobin proportional to the p0, of the blood, 5
 with the wavelength
use , . b900A, (cf. Hoon, et al. 6 ); (3) varying distance between the vaginal
surface and the r)hotonleihysmo g raph; and (4) varying angle between
the -.,zosa and the light bear, emitted by the device.
Or poM 
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1Preliminary work has been done with hard-wired thermistors in a laboratory	 i
setting, 7 but similar location problems have limited the value of the data.
Technic a l Requirement s
In order to generate more useful physiologic data for evaluation of sex	 i
response, a device designed to measure vaginal blood flow must:
(1) be small enough to fit comfortably in the vagina without pressing
against the mucosa firmly enough to alter blood flow (e.g., a
contraceptive diaphragm is usually not felt by the wearer once
it is in place),
(2) be capable of remaining in a relatively fixed position relative
to a given area of the vaginal mucosa as the vagina expands
during sex response,
(3) be largely
(4) be capable
producible
among many
(5) be capable
data signa
unaffected by total
of being calibrated
results in the same
subjects, and
of coupling wit- R
Is to a nearby re:
body movement artifact,
quantitatively so as to give re-
subject, and comparable results
otelemetric device to transmit
r `or recording.
The last requirement listed above would permit subjects to generate data
in privacy, thus minimizing whatever artifacts are introduced by the
laboratory setting as well as making data collection acceptable to a much
larger subject population.
As an initial approach, the problem ori g inator suggests considering a device
that would either (1) fit inside the perir^eter of a vaginal diaphragm (most
commonly 60 to 80 min in diameter) or (2) adhere directly to the vaginal
mucosa with a non-toxic adhesive. The lar g er device would probably have
the more strinuent size requirements, i.e., maximally about 2.5 x 2.5 cm.
If the radiotelemetric and device-positionina requirements described can
be met, this approach could possibly be adopted to the measurement of other
parameters of interest to the va g inal physiolo g ist, such as the mucosal
P02, PCO2, and o';, S Aoain, the capacity for data collection in a private
nonlaboratory setting would greatly facilitate the exr,ansion of our
knowledge of vaginal physiology.
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PROBLEM MISC-50
ADVANCED, RUGGED HEARING AID FOR CHILDREN
	
ti
DATE OF PREPARATION:
	 July 1977
INSTITUTIONS:
	 Bureau of Education of the Handicapped,
and NASA Headquarters
PROBLEM ORIGINATOR:	 Dr. Frank Withrow (BEH)
BATEAM PERSONNEL:
	 R. L. Beadles (RTI); E. Engstrom (WISC)
WHAT IS NEEDED:	 A hearing aid of substantially improved design, which
incorporates superior technical features and is specifically designed to
withstand much greater physical abuse without damage than are currently
available hearing aids.
BACKGROUND:	 There are 200,000 or more children in the United States who
have a sufficient hearing loss to interfere with normal acquisition of speech
and language. Fortunately, most of these children do have some useful
hearing remaining; for such children the hearing aid remains the primary
device for compensating the hearing loss. Since a hearing loss of even a
moderate level, if uncompensated, seriously interferes with the normal
acquisition of speech and language and therefore has profound educational
implications, the early fitting and consistent use of a proper hearing aid
is one of the most essential elements if the child is to succeed in the
hearing world.
SPECIFICATIONS:
I. Physica l and environmental requirements
So far as level of physical activity is concerned, a child who wears a
hearing aid is no different from any other healthy child.
	 Specifically, a
hearing aid worn by a child will be subjected to substantial shock, vib-
ration, and occasionally immersion in water. That hearing aids presently
available for children are inadequate to withstand these environmental
stresses is well demonstrated by studies of hearing impaired children which
show that typically one-third to one-half the hearing aids that these chil-
dren wear are not working properly at any one time. A major redesign of the
nearin g
 aid for children with emphasis on making the aid as child proof as
p racticable is clearly in order.	 Specifically,
A. Aids must be packaged for- children in a rugged format which allows
for functional operation within a wide ranqe of humidity and
temperature cor itions. The aid should be able to withstand con-
siderable shock and vibration as well as be waterproof (or have a
failsafe feature such as moisture-activated shutdown).
E. The aid should be designed with easily operated rugged control
settings. However, an override lock should be available so that
children can be prevented from playing with the controls.
C. Cords for body aids of CP.OS headworn aids should ht ,
 designed so
that they are virtuall y
 indestructible if thev art ,
 used at all.
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II. Technical and performance requirements
In addition to the need for making a hearing aid for children which is
essentially child proof, there are a number of important technical features
each of which has the potential for providing significant added benefit
over present designs. In particular, the following three factors must be
addressed:
The normal external ear and ear canal provide substantial shaping
of the speech frequency range through acoustic resonances.l
Specifically, in the 3,000 to 4,000 Hz range, these resonances
provide at least a 15 dB boost relative to the response at 1 KHz.
The frequency response of the advanced, rugged hearing aid for chil-
dren should be capable of being set to match that provided by these
normal resonances (to a tolerance of + 2dB).
2. A major functional limitation of present hearing aids is the
serious degradation of speech intelligibility in noise relative
to performance in quiet.	 Methods for increasing the signal to
noise ratio at the wearer's ear must be incorporated; one example
of such a method is a highly directional microphone.
3. Although a person with a 90 dB hearing loss may have significant
useful hearing, the problem of acoustic feedback limits the maxi-
mum useable gain of a headworn hearing aid to no more than approxi-
mately 50 dB and that of a body aid to no more than approximately
60 dB even when a tight fitting, unvented earmold is used.
Particularly for young children, achieving this useable gain re-
quires that earmolds be frequently replaced as the child grows;
replacing of earmolds at 3 month intervals is not uncommon for
young children if they are to obtain these levels of gain without
feedback.
"he several advantages of headworn hearing aids over bodyworn aids have not
been Full y utilized because of the useful qain advantage of the bodyworn aid
;ver the headworn aid because of the acoustic feedback problem. There are
3 nur:ber of _ hnical approaches to solving the p roblem of acoustic feedback.3,4
he advanced, rugged hearing aid for children must incorporate features which
er3;le the gain before feedback to be increased by at least 10 dB.
:r 3idition to the above factors, the followin g general performance require-
-en-s, largely representative of p resent hearing aids, must be met:
Frequency res ponse should be adjustable so that the aid can be
tailored to meet the needs of individual children. 	 True flexibility
in the shaping of frequency gain characteristics should be developed.
minimum acce p table frequency response range should be 200 to
6000 Hz (HAIC).
,he minimum acoustic (1a in at the maximu -1 vol ure control setting
shall be 60 dC at 100o H.•.
0R
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C. Maximum Power Output control shall be independent of the gain
control (+ 3 dB).
D. Maximum Power Output shall be adjustable, but should not exceed
135 dB (-3, +0 dB).
E. Distortion such as intermodulation at different frequencies, transi-
ent responses, and peaks in responses should be eliminated.
F. Performance shall remain within specification with a change of
10% in battery voltage.
G. The electronic signal to noise ratio shall be at least 40 dB.
H. Consideration shall be given to the inclusion of a cost effective
malfunction detection unit.
REFERENCES
1. Mehrgardt, S, and V. Mellert (1977).	 "Transformation Characteristics
of the External Human Ear," J. Acoust. Soc. Am. 61, 1567-1576.
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724-739.
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	 "Reverberation Time Con-
trol by Direct Feedback," Acustica 24, 33-41.
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PROBLEM MISC-51
INSTRUMENTATION FOR ACOUSTIC FETAL ASSESSMENT
DATE OF PREPARATION;	 September 19, 1977
INSTITUTION:	 Sinai Hospital
Baltimore, Maryland
PROBLEM ORIGINATOR:	 Phillip J. Goldstein, M.D.
BATEAM PERSONNEL	 H. Clark Beall
WHAT IS NEEDED:	 Electronic circuitry is needed which converts instru-
mentation output from scales of millimeters of mercury to decibels.
BACKGROUND:	 In problem pregnancy cases, the well being of the fetus can
be assessed at intervals during the last trimester of pregnancy by means
of the oxytorin hormone challenge test. The response of the fetus is
111(1111t.ored durinij the cycle~ of mild contraction s, of Lhe womb that are caused
by the injection of a small quantity of the hormone into the mother's
bloodstream. The challenge test is widely used, although sometimes it
causes the premature onset of birth. For this, and other reasons, efforts
are under way to develop different types of fetal assessment tests.
Of the fetal sensory organs, the auditory sense is most mature during the
last trimester. It is logical to investigate whether a fetal assessment
test can be developed that utilizes auditory stimulation. The problem
originator	 believes that he has the proper facilities and personnel to
develop such a test.
The RTI team has responded to the originator's enquiry for technical help
in the experimental design of the auditory fetal assessment test. After
discussing the technical and experimental aspects of the test with the
problem originator, it appears that the RTI team can contribute technical
expertise in the specification and design of some of the instrumentation.
In particular, the capability of one instrument would be enhanced by con-
vecting it into an audiometer with an output scale reading directly in
decibels. This ~could eliminate the manual conversion of data that is now
required.
P ROBLE 1 1 STATUS:	 The RTI team has provided a quantity of technical litera-
ture that should enable the investigator to modify the electronics of their
instrument so as to achieve the proper output scale for his data. No
further- assistance to the investigator is anticipated.
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IMPROVED OPTICS FOR VITRECTOMY SURGERY
DATE OF PREPARATION: 	 June 20, 1977
INSTITUTION:	 The Eye Research Institute of
Retina Foundation
PROBLEM ORIGINATOR:	 Dr. Oleg Pomerantzeff
BATEAM PERSONNEL:	 Doris Rouse
WHAT IS NEEDED:	 An optical device for visualization of the peripheral
vitreous during surgery.
BACKGROUND:	 The vitreous humour is the transparent jelly that fills the
posterior 80 percent of the globe of the eye. Intravitreous opacities
resulting from hemorrhaqe or inflammation often result in a permanent pro-
found hr.-, of vi ,,iun.
	 'litreou ,, hemorrhaqus occur as a c,un ►plication of a
variety of diseases, including diabetes mellitus, sickle cell disease,
hypertension, arteriosclerosis, and Eales' disease, as well as trauma to
the head and directly to the eye. 	 If there is no substantial clearing of
the hemorrhage within six months, a vitrectomy surgery is performed in an
attempt to restore vision. In this surgery, an instrument called the vitreous
nibbler is introduced into the eye to dissect the opaque vitreous, aspirate
the tissue, and infuse fluid to maintain proper intraocular pressure.
(See Fig. 11.)
Visualization of the vitreous near the retina requires placement o` a
contact lens on the cornea and the use of an operating microscope (See Fig. 12.)
The purpose of the lens is to neutralize the refractive power of the cornea
so that areas in the posterior vitreous cavity are brought to a focus in
the anterior vitreous cavity. Thus, the image comes within the focusing
range of the operating microsco pe and appears erect and clear. 	 (See Fig. 13.)
However, this lens per-its onl y a narrow field of view and does not allow
visualization of the peri p heral vitreous. Thus, removal of o pacities in
these areas is not possible.
One technique currently em p loyed to obtain visualization of the entire
fundu; and v i treous cavity is the Goldmann three-mirror contact lens.
(See Fi q . 14.) A flat contact l ens with a sin g le adjustable mirror has also
been developed. These lenses, however, are 15 mi ll hick and, thus. too bulky
for convenient use in surgery.
CONSTRAINTS AND SPECIFICATIONS:
	 Functional requirements for an optical
device for visualization of the vitreous reri^,heral to the equatorial reqion
are as follows-
1) Smal l size, preferably no lar ger than the 2.3 mm x 10 r lur contact
lens used currently frr direct visualization of the posterior
vitreous,
2) The capability of shar p chromatic and spatial resolution, and
3) Suitability for use with an operatinq microscope.
y
Ae piration
Cutting edge
infusionDiameter 1.28 mm
Osciilw,InQ
inner tube
Figure 11.
	 Oscillating vitreous cutter (vitreous stripper) developed by
Kloti.	 (From Kloti, R.:Vitrektomie. II. Chirurgische Technik
mit dem Vitreous Stripper. Albrecht v. Graefes Arch. Klin.
Jhen operating room slit lamp is used during clused
titrectomy, slit illumination ksl) is positioned 5
:u 20 degrees from the observati0" d\is (oa). Con-
.act lens (cl); on the cornea. nibbler (n) in the
Citreous.
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Figure 13. Op tical p rinciple of posterior fundus contact lens.
Fizire 14.	 Optical p rinciple of Goldmann three-mirror contact lens. A_.
Composite picture of tfiree-mirror contact lens. B. Sketch of
fundus. C. Section of vitreous cavity. Areas of vitreous
cavity and fundus viewed w'th different parts of three-mirror
lens are illustrated.	 Central part of mirror (I)- equatorial
mirror (II): ; per,pherol O rror (III). gonioscopic mdrror
(IV). Angle of inclination of each mirror is shown in C.
PROBLEM STATUS:	 Fresnel lenses are currently being used in the treatment
of diplopia (double vision) to shift the image in one eye so that it is
focused on the same area of the retina as in the other eye. The problem
originator has experimented with the use of these Fresnel lenses to
visualize the peripheral vitreous with some success. Problems of chromatic
and spatial resolution may be overcome by developing a lens designed for
use with a microscope.
The RTI BATeam is investigating NASA's capabilities in the design and fabri-
cation of Fresnel lenses.
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PROBLDI GCCC -2
SCA RECEIVER FOR THE HANDICAPPED
DATE OF PREPARATION: May 5,	 1977
INSTITUTION: Guilford County Communications Center for
the Deaf, Greensboro, N.C.
PROBLEM ORIGINATOR: Ms. Peggy Bull	 Nelson,	 Director
BATEAM PERSONNEL: H. Clark Beall
WHAT IS NEEDED:	 A low cost Subsidiary Communications Authorization
receiver and decoder for reception of SCA subcarrier broadcas t - for the
handicapped.
BACKGROUND: The Greensboro, North Carolina, area is perhaps the most active
reqion in the United States, per capita, in providing a means of telephone
c.uuurunicaLion for the de,rf.	 Lmphasis has been placed on equipping dll of
the homes of the deaf with Teletype (TTY) machines and acoustic couplers.
To date, more than 320 such installations have been completed in North
Carolina, with more than 150 units being within a 40-mile radius of
Greensboro.
Although the system was originally conceived as an emergency communications
means for a deaf person, a widely appreciated secondary utilization has
developed. The deaf now use the TTY to talk informally with one another
vii phone. The Guilford County Communications Center for the Deaf (GCCCD)
compiles daily information of special interest to the deaf, such as announce-
men-s of education opportunities, social events, job openings, and local
news. A paper tape T'iY transmission, of about ten minutes in duration, is
available to the TTY stations of those individuals who phone the GCCCD daily
and request the newsletter. However, because of the large number of TTY
stations in the Greensboro area, queueing problems develop when more than
one TTY station attempts to obtain a transmission during the same time
period that a transmission is in progress to another )tation. The situation
is especially severe in the evenings. Also, due to the rural environment,
most of the T"iY stations must make a toll phone call.
GCCCD has requested that the RTI team investi gate what is available as a
radio broadcast means whereby several daily broadcasts of TTY machine code
from GCCCD could reach virtually all of the TTY stations of the Greensboro
area.
The RTI team has investigated this problem and has determined that radio
transmission is indeed feasible not only for the Greensboro area, but for
any other geographical area which would desire to establish a limited audience
broadcast capability to reach a handicapped audience.	 In fact, the FCC has
recently revised its rules to permit both "aural' and "visual" transmission
modes on the Subsidiary Communications Authorization (SCA) subcarriers avail-
able to FM stations of the FM broadcast band. The "visual" mode refers to
the transmission of audio-encoded information that the receivin g
 station
decodes back into a visual format.
	
Examples of "visual" modes that are per-
mitted include slow-scan TV, facsimile, and TTY
There are several commerical sources of equipment for SCA transmission and
reception. This equipment is sold to FM stations that desire to establish
"Storecast" music on the SCA subcarrier as a commercial subscription
service.
	
Representatives of the FM station install and maintain the SCA
decoder units at each subscriber's site. The price of the reception decoders
is too high to be considered appropriate for a broadcast service for the
handicapped. The RTI team activity will focus on making available a low
co^;t SCA decoder- device for the handicapped market at a much lower price
than the currently available units.
It is of interest that the blind have utilized the SCA for the last ten years
as a basis of their' radio readin g service for the blind. At the present
time, the blind must purchase their SCA receivers from commerical sources.
As a result of the hiqh cost of the decoders, the audience for the radio
reddlntl service has not grown as expected.	 Thus. the device that the RTI
team proposed to bring to the marketplace tor- the handicapped should be
flexible enough to be used b y both the blind (whet already utilize the SCA
in half a dozen states) and the deaf (who can perhaps share programminq
time on the SCA stations being utilized by the blind). The national organi-
zations for the deaf and for the blind already have the capability to serve
as warketin q and distribution center~ for specialized devices such as the
SCA decoder.
In sunr,ary , the Greensbot'o, N.C.. area can serve as a nodel s ystem for the
develo pment of services and devices for the deaf. The development of SCA
broadcast can,lblllty in the lil'et"15bo1'0 dt'ea can 5t't'Ve dSa 1) ototvr) system
which can be duplicated in Many other site, havinkt larger geo g raphical areas
and ni:rher no p ul,rtion den0ties.
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PROBLEM MISC-48
SIMPLE, PRESETTABLE TORQUE, BRAKE SYSTEM
DATE OF PREPARATION:	 May 15, 1977
BATEAM PERSONNEL:	 H. Clark Beall
WHAT IS NEEDED:	 A means of easily and reliably presetting braking torque
on an exercise machine.
BACKGROUND:	 A national distributor of physical-therapy devices requested
Team assistance in suggesting a means of presetting the braking torque on
the rotary handle mechanism of an exercise machine. As presently con-
figured, the braking torque is delivered by a shoe brake mechanism that
presses against the outer polished circumference of an axial brake drum.
This type of brake is very difficult to reset to a given value of braking
torque.
CONSTRAINTS AND SPECIFICATION: The problem restrictions are that the
solution be easy to implement, low in cost, and involve no major change in
configuration of the exercise machine.
PROBLEM STATUS: A solution has been found and is beinq evaluated by the
or•oblem originator.
.i
PROBLEM MISC-49
MICROWAVE THERMOGRAPHY
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DATE OF PREPARATION: 	 May 30, 1977
INSTITUTION:	 East Virqinia Medical School
PROBLEM ORIGINATOR:	 Mr. Ken Carr
BATEAM PERSONNEL:	 Doris J. Rouse
14HAT IS NEEDED:	 Microwave instrumentation for the detection of sub-
surface temperature anomalies typical of cancerous growth with high spatial
resolution.
BACKGROUND: Conventional thermograph y at infrared frequencies (>- . 10 GHz),
a tool in the detection of breast cancer for many years, can detect thermal
profiles, at the ,kin's surface only. Subsurface thermal anomalies, such
.r. t hwr e produced Iry certa i n cancerous growth-,, arc indirectly  measured to
the extent that these sources of heat affect the thermal profile at the
surface by the processes of thermal conduction and convection. The in-
ability to measure directly the subsurface thermal profile is a significant
deficit of infrared thermography because (1) there is no way to discrimi-
nate surface and subsurface contributions to the measured thermal profile
at the surface, and (2) thermal dispersion seriously degrades the spatial
resolution for detection of heat sources buried beneath the surface.
Microwave thermography can be thought of as a low-frequency analo g of infra-
red therrno g raphv. A shift to lower frequencies permits the detection of
t rierr,al profiles at depths of up to several cm below the body's surface.
This phenomenon is illustrated, in the graph (see Fig. 1) of r-icrowave
penetration denths in Different biological tissues at different
frequencies.
The selection of microwave frequency for optimal detection of breast cancer
is ar extremely complex matter.	 It is difficult to select such a single
f re q uencv because detailed knowled ge of the internal thermal fields of the
hu-an body is sparse. The specification of thermal field disturbances pro-
ducei b ­ cancerous g rowths of different sizes, locations, and sta ges of growths
within the breast is, if not i r• Dossible, nearly impossible.	 At first glance,
the -~icrowave penetration data shown in Figure 1 5 would arnue for the use of
low frequencies for the detection of dee p -lying cancers.	 It is noteworthy,
however, that s patial resolution decreases as wavelength increases (frequency
is inversel y proportional to wavelength). The utilit y of noninvasive means
for the detection of breast cancer is often qauqed b y the system's ability
to detect a tumor s phere 1 cm in diameter. Tumors of this size can be ef-
fec'i ,3ely treated b y sur riery, chemotherapy, X-radiation, or a combination of
these treatiient modalities.	 The average size of cancers found by physical
exa mination is 3.5 cm in diameter.	 In approximately 65 percent of such
cases, the cancers have nretastasi zou. sharpl y reducing survival ex pectanc y . The
s patial resolution of a microwave thermo g ra p hy system is controlled by the
selection of microwave frequency and the design of the antenna, which couples
i r,icrowave energy from the body to the detector.
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Microwave thermography has been explored by Barrett and Myers 
1,2 
and by
Bigu del Blanco and Romero-Sierrd , as a possible means to measure directly
the subsurface thermal profiles in animal tissue. Most of the work of Barrett
and Myers has been with a 3.3 GHz radiometer coupled to the body with an open-
ended, dielectric filled, X-band waveguide. Barrett and Myers have also con-
ducted preliminary investigations at 10, 5, and 1.3 GHz. 	 Bigu del Blanco
and Romero-Sierra have measured microwave emission from the body at 9.2 GHz
with a refined version of a Dicke radiometer operating on a self-nulling
principle coupled to an airfilled antenna placed some distance from the body.
The optimal frequency for the best depth penetration versus spatial reso-
lution, however, has not yet been determined.
CONSTRAINTS AND SPL-CIFICATIONS:
1. To determine the optical operating parameters for a spatial resolution
of approximately 0.3 cm with an effective depth of penetration in the
breast tissue of 2 cm.	 (This compares favoral,ly with the 1 cm x 2.3 cm
resolution obtained by Barrett and Meyers at 3.3 GHz.)
2. To sample an array of subsurface temperatures simultaneously for en-
hanced clinical applicability.
PROBLEM STATUS: A commercial organization in the field of microwaves is
interested in applvinq NASA technology in this area to the problem of c?ncer
detection. A vice president from this company has visited Langley Research
Center to explore possible interaction with their efforts to develop clinical
instrumentation for microwave heatin q_ of tumors. Dr. Jir 5eebe of NASA
Scientific and Technical Information Facility is working with the RTI BATeam
on the development and commercialization of this promisinc dia gnostic technique.
REFERENCES
A. H. Barrett, and P. C. Myers, "Microwave Thermograohv: A Method of
Detecting Subsurface Thermal Patterns," Thermo raphv, r c r c	 Eu. 1st	 E—
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PROBLEM UGA-1
AEROSOL VACCINATION SYSTEM
DATE OF PREPARATION:	 May 31, 1977
INSTITUTION:	 University of GA, Veterinary Medicine Department
PROBLEM ORIGINATOR:	 Dr. S. H. Kleven
BATEAM PERSONNEL:	 Dr. R. W. Scearce
WHAT IS NEEDED:	 An aerosol generation system which controls the particle
size distribution and determines the effective exposure dosage.
BACKGROUND: Poultry production and processing is a major industry in GeorgiZ
(b2 in U.S. broiler Production) and represents a significant element in that
state's agricultural economy.	 It is still a highly labor intensive industry
with extremely small per unit profit margins and dependent upon large volume
production for financial success. Flocks of 20,000 to 30,000 birds are common.
These large flocks are vulnerable to contagious diseases. Plarek's disease
and Newcastle disease are two of the most deadly. In the past, outbreaks of
either of these have nearly destroyed the poultry industry in large sections
of the country. Fortunately, today vaccines are available to protect against
both of these diseases, but innoculation of large flocks of birds poses
several problems. One possible solution is to administer the vaccine by spraying.
The technique of applying vaccines in aerosol form has seen very limited use
because the details of this technique have not yet been adequately defined. Its
effectiveness appears to be a function of several factors, including type of
vaccine, droplet size, and depth of penetration in the airway. The Disease
Research Center in Athens, Georgia, is ver y interested in studyin g the dynamics
of this technique in order to develop an effective innoculation system. The
availability of such a system would be of considerable benefit to the ooultry
industry. Unfortunately, the Disease Research Center has neither the expertise
in aerosol generation and dynamics nor the necessary equipment to conduct this
study.
PROBLE M, STATUS: JPL is working closely with the Department of Avian Medicine
to apply aerosol expertise and equipment developed in support of the Viking
Project. Vaccine producers and aerosol neneratinr. equipment manufacturers
are being identified to collaborate in this protect.
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PROBLEM DU-99
V-SLOTTED HEAD SCREWS
ORIGINAL PAGE IS
OF POOR QUALITY
DATE OF PREPARATION
	
June 30, 1977
INSTITUTION:
	
Duke Medical Center, Rehabilitation Center
PROBLEM ORIGINATOR:
	
Mr. Burt Titus
BATEAM PERSONNEL:
	
Dr. R. W. Scearce
WHAT IS NEEDED: A fastner is needed which will resist screw driver cam out
and requires a special tool to adjust.
BACKGROUND: The manufacturers of prosthetic and orthotic devices are faced
with rapidly increasing costs. Key materials, which are used extensively, are
involved in international pricing wars. This, added to increasing wages, has
put these manufacturers in a very difficult position. Since medical insurance
pay, for most of the devices, the maximum for which a device can be sold is
limited. This makes the situation even worse. Thus, unnecessary manufacturing
costs cannot be tolerated.
Often it is necessary to make minor adjustments to braces and various prostheses.
These adjustments involve loosening screws. All toc often the screws cam
out and must be replaced. Replacement requires drilling out the remains
of the screw. What should have been a five-minute job becomes a thirty-
minute job. If some type of fastener which would reduce or eliminate this
problem were available, it would make a significant contribution towards
controllinq manufacturing costs.
	 If such a fastener required a special tool
to loosen it, it would also help lirit the unofficial g race adjustments made
by the patient, his family, and friends.
CONSTRAINTS AND S°ECIFICATIONS: A low cost fastener .-,nich resists cam out is
needed.	 It is also desired that a special tool be rewired to loosen this
fastener.
PROBLEM STATUS: 4rrangements have been made to obt3i r, s3^i p ies of V-slotted
head screws to evaluate.
ORICIVIA! PACE 13
PROBLEM GCCC-1	 OF POOR QUALITY
A TELETYPE MACIIINI ILST UNIT
DATE OF PREPARATION: 	 March 15, 1977
INSTITUTION:	 Guilford County Communications Center for
the Deaf, Greensboro, N.C.
PROBLEM ORIGINATOR:	 Ms. Peggy Bull Nelson
BATEAM PERSONNEL:	 Dr. H. Clark Beall
WHAT IS NEEDED:	 A portable, low cost electronic signal generator for
testing Teletype machine operation in the home of the deaf.
BACKGROUND: A profoundly deaf person has need to use the telephone system,
but such utilization is limited by the very nature of his handicap. Especially
is this true when the deaf person attempts to summon emergency services (fire,
police, and rescue) to his home. In attempting to address this problem, the
Sertoma Club (a civic club) has instituted a program in "forth Carolina (and
elsewhere) to equip emergency services communications centers with Teletype
(TTY) machines. After installation of a TTY at a cormunications center, an
effort is made to equip the homes of all the deaf of the city with a TTY set.
Each of these machine installations is interfaced to the p hone system by an
acoustic coupler. A state-wide telephone directory lists a l l the phone numbers
of the holders of such TTY equipment. Such a directory enables the deaf to use
the TTY for nonemergency purposes, such as communicating ir r_rmally with other
dead individuals.	 Nationwide, there are more than 5,100 irs_a"lations in
homes of the deaf.
At the present time, the TTY system does provide emer gency com—unications for
some of the deaf population. However, there are serious orobllems in attempting
to 'p rovide such equi pment to all of the deaf population. "re RTI Tear- has
established an interest in solving these problem.
of cost reduction.
c p uld sim p ly purchase
not the case. There-
c_st of establishing,
.lute • , , inimum so that
The central theme of any project in this area must be tha.
Obviously, if each deaf person had unlimited resources, he
a new TTY system for his private use. But this is usually
fore, the purpose of the Team effort will be to reduce the
maintaining, and o perating a reliable TTY s y stem to an abs
any ,leaf person who desires one can afford it.
Virtually all of the TTY machines in the program are aged odel 15 reach'lnes that
were obtained when the nevrs wire services changed to nev. and faster- TTY
printers.
	
Everyone in the prograiii agrees that the TTY r:ach-nes are not too
de pendable, require regular raintenance, and are not too cesir3tle because
they use the old 5-bit Baudot TTY code instead of the r,odern ASCII code.
However, for the immediate future. they machines are serving a useful purpose.
For t l^is reason, several nrot, lem- unique to TTY machines wil' tie investigated
first.	 Later, specific !eans of rehlacino the TTY machine: 	 electronic
disolav devices will be investigated.
CONSTRAINTS AND SPECIFICPT!ON^: Inc ,ioh or maintaining a la n ce , umber of
:achires 'n workin g_ order is a technical t,isl, that has been ?ssumed b y sev
of t"o deaf in the Green;boro. N C . .ire,i	 "here is ie{iri-_ r eed for a
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portable device which can be used by these technicians to test the operation
of the TTY machine in the home of the deaf. Often. an adjustment of the
machine's mechanism can be made in the home. Without such a test device.
the TTY must be removed from the home and returned to the central service
center for testin g and adjustment.
It is desired that the TTY test unit be compact and portable. Preferably,
it should be battery operated. The unit must originate on/off current
pulses ry reed-relay contact closures. The machine character code that
it genei •ated must he fill wpm Batidot TTY cede.
The cost of the test unit must be held to an absolute minimum.
(1RmIN1'^  L PV-7 I5
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PROBLEM TU-43
CRANIAL BLOOD FLOW MONITORING
DATE OF PREPARATION:	 March 15, 1977
INSTITUTION:	 Tulane Medical School, Neurosurgery
PROBLEM ORIGINATOR:	 Dr. R. F. Llewellyn, Chairman
BATEAM PERSONNEL:	 Dr. H. Clark Beall
WHAT IS NEEDED:	 A means for long-term monitoring of cerebral blood flow
and/or cerebral tissue oxygen tension.
BACKGROUND: Following acute cerebral insult, there is scientific evidence
to support the theory that most of the resulting brain damage is due to
severe reduction in blood supply to the brain. Oxygen and glucose must be
continually provided to the brain by the blood because the brain tissue does
not contain any stores of these substances. When the cerebral blood Flow (CBF)
is reduced to a critical level of 40 percent of normal, the brain vascular
s ystem cannot further adapt and the tissue metabolism changes from aerobic
metabolism to anaerobic metabolism as the oxygen supply continues to fall.
Low oxygen tension causes reduced ritochondrial phosphorylation and neuronal
activity diminishes.	 The patient can then lose consciousness and develop
serious clinical problems.
The normal CBF in awake man is approximately 50 ml/100 g/min and the cerebral
metabolic rate of oxygen utilization (CMR0 2 ) is approximately 3.5 rr,1/100 9/min.
if the metabolism remains normal as CBF falls, low blood flow oxvoen starvation
of the brain occurs when CBF declines to about 20 ml/100 g/min. But, if the
metabolic rate decreases, the ox.; gen demand also declines (as in the case of
hypothermia). Tnerefore, measurements of CMR02 (and CMR glucose) are as
important as measurements of CEF in the treatment of brain insilts.l
REFERENCES
1.	 T. W. Lanc.fitt. "Clinical r,ethods for monitoring intracranial pressure
and mPasu r ina cerebral blood flow, Clinical Neurosurg	 :30: X1975).
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PROBLEM WF-126
A LONG-TERM INTRACRANIAL FLUID PRESSURE MONITOR
DATE OF PREPARATION: 	 March 15, 1977
INSTITUTION:	 Bowman Gray School of Medicine
Wake Forest University
PROBLEM ORIGINATOR: 	 Dr. C. P. McGraw
BATEAM PERSONNEL:	 Dr. H. Clark Beall
WHAT IS NEEDED:	 A fluid pressure monitor that can be installed for long-
term monitoring of intracranial fluid pressure.
BACKGROUND: The clinical value of continuous intracranial pressure (I;P)
monitorin g in the management of patients with head injury is well established
in the medical literature.
	
Investigations have shown that clinical signs,
particularly vital signs, are unreliable i , i indicating the rise in ICP that
often follows severe head injury. For this reason, a method of directly
monitoring ICP has obvious advantage's as clinical management can be more
securely based if ICP is directly and continuously measured.l
At the present tivie, when a decision is made to install an ICP monitor device,
a burr hole is made in the skull into which the device can be seated and sealed.
Typic.fll/, the burr hole is 15 mm or iess in diameter.
The ICP elevation above atmospheric can be ex pected to be 20 mm Hg in the most
severe cases. However, atmospheric pressure itself typically can change by
as rruch as 50 mr, Ho over the period of a mcnth, due to the passage of storm
fronts and other such atmospheric disturbances. Therefore, if one expects
to utilize an absolute p ressure transducer ;in which the reference p ressure is
zero Mm rig;, the value of clinical significance, ICP, represents a variation
of 2C rr • Ho and rust be measured with 1 percent accuracy in the face of at-
mospheric cressure .0-.ich is some thirty-ei g ht-f,ld larger (760 vin Hq + 25).
In t ► • e --ast is ears, nuv ,erous technioues r ake teen utilized for continuously
r •easu ,• ir-	 -	 Search for an optimal device and technique continues. 	 There
are several ­eauire:-ients a potential device must address:
recor•dina trust be f roc the intracranial s pace.	 Subarachnoid
'.J"h a t ^ ►'e ssure no lenaer is considereJ to acc:,ratel y reflect ICP.
;_' '
-le device ,sed to :, ieasure ICP sne^ld not ;roduce brain damage.
T r e-e should be little or no ris ►, ^f i n'ection.	 Any method that re-
quires a continuous column of fluid fr,,r a cerebro-spinal fluid space
(CSF` to an external transducer carries :rite it a risk of infection
that is :?renter than a technique *_nit does not violate the intradural
soave.
technique that does not reco rd oressure directly from a CSF space
gust .e demonstrated to be as accurate ane reliable as one that does
""cord fror the ventricle or subar • achnoid space.
(5	 ne 'requencv response of a transducer rust be satisfactor y and the
• e •- aeratu re sensitivit y of the irst r a-,ent crust be minimal.
B- 33
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(6) The transducer must be drift-free, or correctable for drift.
(7) The operative procedures for inserting the transducer should be
simple.
The ideal method for continuously recording ICP in man should eliminate all
external connections. The device should be chronically implanted within
the extradural space so as to red^ce the risk of infection and injury of
the brain adjacent to the device.
One possible method is try; use of a chronically implanted capacitance probe
such as is being developed by Mr. Tom Fryer of Ames Research Center and the
Stanford Biomedical Applications Team. However, the objective of oroblem
statement WF-126 is to explore other possihle Solutions to this important
medical need.
REFERENCES
1. G. T. Tindall, et al., "Monitoring of Patients with Head Injuries,"
Clinical Neurosurgery 22:332-363 (1975).
2. T. W. Langfitt, "Clinical methods for monitoring intracranial pressure
and measuring cerebral blood flow," Cli_ical Neurosu rgery 22:302-2G (1975).
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APPENDIX C
CONFERENCES ATTENDED BY AND PRESENTATIONS MADE BY
BIOMEDICAL APPLICATIONS TEAM MEMBERS
P"7.
CONFERENCES ATTENDED BY AND PRESENTATIONS MADE BY ORIGINAL PAGE IS
BIOMEDICAL APPLICATIONS TEAM MEMBERS 	 OF POOR QUALITY
On February 8-9. 1977, Dr. R. W. Scearce attended the World Trade Show
in Chicago, Illinois. He assisted NASA in showing the space technology
exhibit.
2. The Rehabilitation Services Administration Workshop on Internal Joint
Replacement. ;ielkl on March 3-5, 1977, at the Rehabilitation Institute
of Chicago, Chicago, Illinois, was attended by Dr. R. W. Scearce.
Dr. Scearce made a presentation on the RTI Biomedical Applications
Team program at the workshop, and partici pated on the panel on
Functional Evaluation and Mechanics of Joints.
On March 14 -16, 1977, Dr. F. T. Wooten and Mr. J. C. Ruddle of RTI
attended the 12th Annual Conference of the Associa t ion for the
Advancement of Medical Instrumentation in San Francisco, California.
... Wooten and Mr. Robert Zimmerman chaired the session on National
Aeronautics and Space Administration Development.
J. The NASA Technology L i tilization Meeting, held on March 30 and 31, at
the Illinois Institute of Technolo gv Researcn institute in Chicano.
Illinois, was attended by Dr. J. N. Brown.	 Dr. Grown made a pre-
Sentation at the meetinki on the RTI Eiomedical Applications Team
program.
^ln April 1-?, 1977, Dr. R. W. Scearce attended the Rehabilitation
Services Administration Workshop on Prosthetics and Orthotics, in
Miami, FIorida. Dr. Scearce participated a: a panel member on the
panel on Upper Limb Prosthetics.
' lie Convention of the Georuia Association rJ the Deaf.	 O d o- Auqust
11-1", 1977, in At lanta Geor,lia, was attended b y Dr. H. C. I4eal1.
`r. Bea II made a p resentation on the TeIetvpe prrnrr,rm for the deaf,
and demonstrated the teletype test device.
On Septeclber 21 and 22, 1,1'7. Dr. R. W. Scearce at t ended t a le Veterans
Adn•inist ► • at ion!National Aeronautics and Space Admini — ration Conference
on Habitability in Extended Care En y ironnent", held in 'lrnneapolis,
'-Iinnesota.
	 Dr. Scearce participated on the rmrrel to define innl ►ediate
t ec hno 1 ooy needs.
^_. On November 9-11, 1977, Drs. J. N. Brown and R. W. Sce,rrce attended
the meetino on Aerospace Technology Transfer to the Puhlic Sector.
;Ir. Frown chaired the panel on Health Care at this merting which was
Jointly sponsored by the American Institute 01 AeronautiCS and
Astronautics, and the National Aeronautics and lm, ► ce Admrni^tr'atiun..
F''RECED^p p
C- 3	 Wr 8l4MK NOT FIL4M
CONFERENCES ATTENDED BY AND PRESENTATIONS MADE BY BIOM
APPLICATIONS TEAM MEMBERS (CONTINUED)
The Conference on the Application of Technology to wig v.«uzo up o1c
Elderly, was held December 8, 1977, in Baltimore, Maryland.
Dr. R. W. Scearce and Ms. D. J. Rouse attended the conference
which was sponsored by the National Aeronautics and Space Adminis-
tration, and the National Institute for the Aging.
10. On March 8, 1977, Dr. R. W. Scearce presented a program on the
National Aeronautics and Space Administration and Technology Transfer,
at the Crestwood Hospital, in Huntsville,Alabama.
11. On March 15, 1977, Dr. R. W. Scearce gave a presentation on the
Biomedical Applications Team program to a class on Technology
Assessment at the Duke University Department of Mechanical
Engineering and Material Science, in Durham, North Carolina.
12. On March 29, 1977, Dr. R. W. Scearce gave a presentation on the
Biomedical Applications Team program to the local chapter of IEEE
at the Virginia State University, Department of Electrical Engineering,
in Blacksburg, Virginia.
13. The 22nd North Carolina Symposium for Electrical and Electronic
Engineers, held November 3-4, 1977 in Greensboro, North Carolina,
was attended by Dr. R. W. Scearce. Dr. Scearce gave a presentation
on Medical Uses of National Aeronautics and SDace Administration
Technology.
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